| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.55e-08 | 18 | 239 | 6 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 8.34e-07 | 28 | 239 | 6 | GO:0051959 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.87e-06 | 70 | 239 | 8 | GO:0003777 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 4.71e-06 | 37 | 239 | 6 | GO:0045505 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.25e-05 | 118 | 239 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | kinase binding | DAB2IP NBEAL1 ACTBL2 ACTA2 NAIP SYNGAP1 ACSL3 KAT2B PTPN14 SYK PLCB4 QARS1 ADCY4 UBQLN1 TTC28 NSF RELB NR3C1 CASK IBTK MTOR MICAL2 DNM3 AATF PRKG2 MAP2K3 GPRC5B MAP3K2 | 1.51e-05 | 969 | 239 | 28 | GO:0019900 |
| GeneOntologyMolecularFunction | protein kinase binding | DAB2IP NBEAL1 ACTBL2 ACTA2 NAIP SYNGAP1 ACSL3 KAT2B PTPN14 SYK PLCB4 QARS1 ADCY4 NSF RELB NR3C1 CASK IBTK MTOR MICAL2 DNM3 AATF PRKG2 MAP2K3 GPRC5B MAP3K2 | 1.86e-05 | 873 | 239 | 26 | GO:0019901 |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF21B NAIP ACTC1 ATP9B ACSL3 ACSL4 SUPV3L1 MOV10L1 TOR3A DNAH8 DNAH9 DYNC1H1 DNAH3 NSF ABCF2 CCT2 ABCG1 DNAH12 SMC3 DNAH17 | 5.32e-05 | 614 | 239 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF21B NAIP ATP9B SUPV3L1 MOV10L1 TOR3A DNAH8 DNAH9 DYNC1H1 DNAH3 NSF ABCF2 CCT2 ABCG1 DNAH12 SMC3 | 8.84e-05 | 441 | 239 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | kinase activity | BCKDK DGKA DGKG CHKB MAST2 TRRAP ITPKB MET SYK PAK5 CDC42BPB CASK TGFBR1 LIMK1 MTOR NEK8 PPIP5K1 PRKG2 MARK2 MAP2K3 ULK2 MAP3K2 | 1.37e-04 | 764 | 239 | 22 | GO:0016301 |
| GeneOntologyMolecularFunction | glutamine-tRNA ligase activity | 1.43e-04 | 2 | 239 | 2 | GO:0004819 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | BCKDK MAST2 SYK PAK5 CDC42BPB CASK TGFBR1 LIMK1 MTOR NEK8 PRKG2 MARK2 MAP2K3 ULK2 MAP3K2 | 3.31e-04 | 446 | 239 | 15 | GO:0004674 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | BCKDK DGKA DGKG CHKB MAST2 ITPKB MET SYK PAK5 CDC42BPB CASK TGFBR1 LIMK1 MTOR NEK8 PRKG2 MARK2 MAP2K3 ULK2 MAP3K2 | 3.60e-04 | 709 | 239 | 20 | GO:0016773 |
| GeneOntologyMolecularFunction | palmitoyl-CoA ligase activity | 4.25e-04 | 3 | 239 | 2 | GO:0090433 | |
| GeneOntologyMolecularFunction | coumarin 7-hydroxylase activity | 4.25e-04 | 3 | 239 | 2 | GO:0008389 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | BCKDK MAST2 PAK5 CDC42BPB CASK LIMK1 MTOR NEK8 PRKG2 MARK2 MAP2K3 ULK2 MAP3K2 | 4.58e-04 | 363 | 239 | 13 | GO:0106310 |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate phosphatase activity | 5.59e-04 | 14 | 239 | 3 | GO:0004438 | |
| GeneOntologyMolecularFunction | phosphatidylinositol monophosphate phosphatase activity | 6.93e-04 | 15 | 239 | 3 | GO:0052744 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate phosphatase activity | 8.45e-04 | 16 | 239 | 3 | GO:0106018 | |
| GeneOntologyMolecularFunction | cGMP binding | 8.45e-04 | 16 | 239 | 3 | GO:0030553 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF21B NAIP ATP9B SUPV3L1 MOV10L1 TOR3A DNAH8 DNAH9 DYNC1H1 DNAH3 ARL16 NSF ABCF2 CCT2 RGS7 ABCG1 DNAH12 SMC3 TSR1 DNM3 | 1.09e-03 | 775 | 239 | 20 | GO:0017111 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DAB2IP MYCBP2 DOCK11 SYNGAP1 EVI5 ELMOD3 DOCK1 ADAP1 DOCK8 GPS1 LARS1 ECT2L RGS7 ARHGAP6 EIF2B1 | 1.23e-03 | 507 | 239 | 15 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DAB2IP MYCBP2 DOCK11 SYNGAP1 EVI5 ELMOD3 DOCK1 ADAP1 DOCK8 GPS1 LARS1 ECT2L RGS7 ARHGAP6 EIF2B1 | 1.23e-03 | 507 | 239 | 15 | GO:0030695 |
| GeneOntologyMolecularFunction | phosphatase binding | 1.35e-03 | 264 | 239 | 10 | GO:0019902 | |
| GeneOntologyMolecularFunction | L-ornithine transmembrane transporter activity | 1.39e-03 | 5 | 239 | 2 | GO:0000064 | |
| GeneOntologyMolecularFunction | osmolarity-sensing monoatomic cation channel activity | 1.39e-03 | 5 | 239 | 2 | GO:1990760 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | DAB2IP NCF4 LANCL2 ITPR1 SVIL PLEKHA8 ADAP1 SNX33 STAM WDFY3 VPS13B | 1.56e-03 | 316 | 239 | 11 | GO:0035091 |
| GeneOntologyBiologicalProcess | cilium movement | TTC21A MET VPS13A CFAP206 TACR3 DNAH8 DNAH9 DYNC1H1 CACNA1E DNAH3 CFAP91 ARMC12 IFT81 TTLL8 DNAH12 DNAH17 CFAP61 HYDIN | 1.28e-09 | 261 | 235 | 18 | GO:0003341 |
| GeneOntologyBiologicalProcess | microtubule-based movement | KIF21B IFT172 TTC21A MET VPS13A CFAP206 TACR3 DNAH8 DNAH9 DYNC1H1 CACNA1E DNAH3 CFAP91 COPG1 ARMC12 IFT81 AP3B1 TTLL8 ACTR2 DNAH12 DNAH17 CFAP61 HYDIN | 1.22e-08 | 493 | 235 | 23 | GO:0007018 |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | TTC21A MET VPS13A CFAP206 TACR3 DNAH8 DNAH9 CACNA1E DNAH3 ARMC12 IFT81 TTLL8 DNAH12 DNAH17 CFAP61 | 1.98e-08 | 210 | 235 | 15 | GO:0060294 |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | TTC21A MET VPS13A CFAP206 TACR3 DNAH8 DNAH9 CACNA1E DNAH3 ARMC12 IFT81 TTLL8 DNAH12 DNAH17 CFAP61 | 2.71e-08 | 215 | 235 | 15 | GO:0060285 |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | TTC21A MET VPS13A CFAP206 TACR3 DNAH8 DNAH9 CACNA1E DNAH3 ARMC12 IFT81 TTLL8 DNAH12 DNAH17 CFAP61 | 2.71e-08 | 215 | 235 | 15 | GO:0001539 |
| GeneOntologyBiologicalProcess | mesenchyme migration | 8.14e-08 | 5 | 235 | 4 | GO:0090131 | |
| GeneOntologyBiologicalProcess | microtubule-based process | KIF21B SPAG1 IFT172 TTC21A APC2 CUL7 MET KAT2B VPS13A CFAP206 TACR3 DNAH8 DNAH9 DYNC1H1 CACNA1E DNAH3 CFAP91 COPG1 ARMC12 IFT81 AP3B1 TTLL8 ACTR2 DNAH12 SMC3 DNAH17 CEP135 CFAP61 MARK2 HYDIN | 3.99e-06 | 1058 | 235 | 30 | GO:0007017 |
| GeneOntologyBiologicalProcess | organelle assembly | SPAG1 IFT172 ACTA1 ACTC1 CNOT6 EVI5 KAT2B CFAP206 ELMOD3 DNAH8 DYNC1H1 CFAP91 RPGRIP1L UBQLN1 ARMC12 IFT81 GRID2 STAM AP3B1 TTLL8 ACTR2 SMC3 MTOR DNAH17 CEP135 CFAP61 ULK2 HYDIN VPS13B MYBPC1 | 1.64e-05 | 1138 | 235 | 30 | GO:0070925 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | DAB2IP NCKAP1 MYCBP2 DOCK11 DGKG CUL7 ITPR1 SYNGAP1 EVI5 MET KAT2B FIG4 MINAR1 GRID2 ACTR2 CASK TGFBR1 LIMK1 MTOR GLCE CEP135 DNM3 MARK2 ULK2 GPRC5B | 1.90e-05 | 863 | 235 | 25 | GO:0031344 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | SPAG1 NCKAP1 DOCK11 IFT172 EVI5 CFAP206 ELMOD3 DNAH8 CFAP91 RPGRIP1L ARMC12 IFT81 TTLL8 ACTR2 TGFBR1 MTOR DNAH17 CEP135 DNM3 CFAP61 HYDIN | 2.94e-05 | 670 | 235 | 21 | GO:0120031 |
| GeneOntologyBiologicalProcess | cilium organization | SPAG1 IFT172 TTC21A EVI5 CFAP206 ELMOD3 DNAH8 CFAP91 RPGRIP1L ARMC12 IFT81 TTLL8 ACTR2 DNAH17 CEP135 CFAP61 HYDIN | 3.51e-05 | 476 | 235 | 17 | GO:0044782 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | DAB2IP NCKAP1 MYCBP2 DOCK11 DGKG CUL7 ITPR1 SYNGAP1 EVI5 MET KAT2B FIG4 MINAR1 GRID2 ACTR2 CASK TGFBR1 LIMK1 MTOR CEP135 DNM3 MARK2 ULK2 GPRC5B | 3.92e-05 | 846 | 235 | 24 | GO:0120035 |
| GeneOntologyBiologicalProcess | cell projection assembly | SPAG1 NCKAP1 DOCK11 IFT172 EVI5 CFAP206 ELMOD3 DNAH8 CFAP91 RPGRIP1L ARMC12 IFT81 TTLL8 ACTR2 TGFBR1 MTOR DNAH17 CEP135 DNM3 CFAP61 HYDIN | 4.06e-05 | 685 | 235 | 21 | GO:0030031 |
| GeneOntologyBiologicalProcess | cilium assembly | SPAG1 IFT172 EVI5 CFAP206 ELMOD3 DNAH8 CFAP91 RPGRIP1L ARMC12 IFT81 TTLL8 ACTR2 DNAH17 CEP135 CFAP61 HYDIN | 5.38e-05 | 444 | 235 | 16 | GO:0060271 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | DAB2IP NCKAP1 DOCK11 CUL7 ITPR1 MET KAT2B FIG4 ACTR2 CASK TGFBR1 LIMK1 MTOR CEP135 DNM3 MARK2 GPRC5B | 5.57e-05 | 494 | 235 | 17 | GO:0031346 |
| GeneOntologyBiologicalProcess | flagellated sperm motility | TTC21A MET VPS13A CFAP206 TACR3 CACNA1E ARMC12 IFT81 TTLL8 CFAP61 | 5.66e-05 | 186 | 235 | 10 | GO:0030317 |
| GeneOntologyBiologicalProcess | sperm motility | TTC21A MET VPS13A CFAP206 TACR3 CACNA1E ARMC12 IFT81 TTLL8 CFAP61 | 7.71e-05 | 193 | 235 | 10 | GO:0097722 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | DAB2IP MYCBP2 DGKG CUL7 ITPR1 SYNGAP1 MET KAT2B FIG4 MINAR1 GRID2 ACTR2 CASK LIMK1 MTOR DNM3 MARK2 ULK2 GPRC5B | 8.08e-05 | 612 | 235 | 19 | GO:0010975 |
| GeneOntologyBiologicalProcess | mesenchyme morphogenesis | 9.67e-05 | 65 | 235 | 6 | GO:0072132 | |
| GeneOntologyBiologicalProcess | glutaminyl-tRNA aminoacylation | 1.29e-04 | 2 | 235 | 2 | GO:0006425 | |
| GeneOntologyBiologicalProcess | neuron projection development | DAB2IP NCKAP1 MYCBP2 ACTBL2 CDH23 DGKG CUL7 ITPR1 SYNGAP1 ACSL4 MET KAT2B FIG4 VPS13A ELMOD3 MINAR1 SLITRK6 FOXG1 GRID2 NR3C1 ACTR2 CASK FOXB1 LIMK1 MTOR DNM3 MARK2 ULK2 VPS13B GPRC5B | 1.50e-04 | 1285 | 235 | 30 | GO:0031175 |
| GeneOntologyBiologicalProcess | glycerolipid biosynthetic process | DGKA DGKG CHKB ITPKB ACSL3 ACSL4 FIG4 TTC7A ABHD4 MTMR7 DGAT1 | 2.67e-04 | 268 | 235 | 11 | GO:0045017 |
| GeneOntologyCellularComponent | axoneme | IFT172 CFAP206 DNAH8 DNAH9 DNAH3 CFAP91 RPGRIP1L TTLL8 DNAH12 DNAH17 CFAP61 HYDIN | 4.96e-06 | 207 | 239 | 12 | GO:0005930 |
| GeneOntologyCellularComponent | ciliary plasm | IFT172 CFAP206 DNAH8 DNAH9 DNAH3 CFAP91 RPGRIP1L TTLL8 DNAH12 DNAH17 CFAP61 HYDIN | 5.22e-06 | 208 | 239 | 12 | GO:0097014 |
| GeneOntologyCellularComponent | axonemal dynein complex | 8.26e-06 | 25 | 239 | 5 | GO:0005858 | |
| GeneOntologyCellularComponent | motile cilium | IFT172 ACTA2 MET VPS13A CFAP206 TACR3 DNAH8 DNAH9 DNAH3 CFAP91 IFT81 TTLL8 DNAH12 DNAH17 CFAP61 | 1.57e-05 | 355 | 239 | 15 | GO:0031514 |
| GeneOntologyCellularComponent | cytoplasmic region | IFT172 CFAP206 DNAH8 DNAH9 DYNC1H1 DNAH3 CFAP91 RPGRIP1L AP3B1 TTLL8 DNAH12 DNAH17 CFAP61 MARK2 HYDIN | 1.84e-05 | 360 | 239 | 15 | GO:0099568 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | IFT172 CFAP206 DNAH8 DNAH9 DYNC1H1 DNAH3 CFAP91 RPGRIP1L AP3B1 TTLL8 DNAH12 DNAH17 CFAP61 HYDIN | 1.85e-05 | 317 | 239 | 14 | GO:0032838 |
| GeneOntologyCellularComponent | 9+2 motile cilium | IFT172 MET VPS13A TACR3 DNAH8 DNAH9 DNAH3 IFT81 TTLL8 DNAH12 DNAH17 CFAP61 | 2.03e-05 | 238 | 239 | 12 | GO:0097729 |
| GeneOntologyCellularComponent | dynein complex | 3.42e-05 | 54 | 239 | 6 | GO:0030286 | |
| GeneOntologyCellularComponent | lamellipodium | NCKAP1 APC2 ACTA1 ACTA2 ACTC1 ACTG2 PTPN13 DOCK8 CDC42BPB ACTR2 LIMK1 | 7.23e-05 | 230 | 239 | 11 | GO:0030027 |
| GeneOntologyCellularComponent | supramolecular fiber | KIF21B CYP2A6 CYP2A7 NCKAP1 ACTBL2 APC2 ACTA1 ACTA2 ACTC1 ACTG2 KAT2B SVIL SCN8A CFAP206 DNAH8 DNAH9 DYNC1H1 DNAH3 RPGRIP1L AKNA CCT2 TTLL8 ARHGAP6 DNAH12 MICAL2 DNAH17 DNM3 MARK2 MYBPC1 | 8.55e-05 | 1179 | 239 | 29 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KIF21B CYP2A6 CYP2A7 NCKAP1 ACTBL2 APC2 ACTA1 ACTA2 ACTC1 ACTG2 KAT2B SVIL SCN8A CFAP206 DNAH8 DNAH9 DYNC1H1 DNAH3 RPGRIP1L AKNA CCT2 TTLL8 ARHGAP6 DNAH12 MICAL2 DNAH17 DNM3 MARK2 MYBPC1 | 9.62e-05 | 1187 | 239 | 29 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KIF21B CYP2A6 CYP2A7 NCKAP1 ACTBL2 APC2 ACTA1 ACTC1 SVIL CFAP206 DNAH8 DNAH9 DYNC1H1 DNAH3 RPGRIP1L AKNA CCT2 TTLL8 ARHGAP6 DNAH12 MICAL2 DNAH17 DNM3 MARK2 | 1.07e-04 | 899 | 239 | 24 | GO:0099513 |
| GeneOntologyCellularComponent | microtubule | KIF21B CYP2A6 CYP2A7 APC2 SVIL CFAP206 DNAH8 DNAH9 DYNC1H1 DNAH3 RPGRIP1L AKNA CCT2 TTLL8 DNAH12 DNAH17 DNM3 | 1.46e-04 | 533 | 239 | 17 | GO:0005874 |
| GeneOntologyCellularComponent | somatodendritic compartment | DAB2IP KIF21B PDE2A NAIP SNAP47 ITPR1 SYNGAP1 ACSL4 MET VPS13A SCN8A TMEM266 PLCB4 TACR3 MME DYNC1H1 CACNA1E ADCY4 NSF GRID2 NR3C1 RGS7 CASK CNNM4 MTOR DNM3 WDFY3 MARK2 HDAC1 | 1.72e-04 | 1228 | 239 | 29 | GO:0036477 |
| GeneOntologyCellularComponent | cell body | DAB2IP ACTA1 ACTA2 NAIP ACTC1 ACTG2 SNAP47 ITPR1 ACSL4 MET PTPN13 VPS13A SCN8A TMEM266 TACR3 MME DYNC1H1 CACNA1E CCT2 CASK CNNM4 MTOR WDFY3 HDAC1 | 1.75e-04 | 929 | 239 | 24 | GO:0044297 |
| GeneOntologyCellularComponent | cilium | IFT172 TTC21A ACTA2 CDH23 MET VPS13A CFAP206 ELMOD3 TACR3 DNAH8 DNAH9 CNGA1 DNAH3 CFAP91 RPGRIP1L IFT81 TTLL8 CASK DNAH12 NEK8 DNAH17 CFAP61 HYDIN | 2.71e-04 | 898 | 239 | 23 | GO:0005929 |
| GeneOntologyCellularComponent | actin filament | 2.82e-04 | 146 | 239 | 8 | GO:0005884 | |
| GeneOntologyCellularComponent | outer dynein arm | 3.01e-04 | 12 | 239 | 3 | GO:0036157 | |
| GeneOntologyCellularComponent | dendrite | DAB2IP KIF21B PDE2A SNAP47 ITPR1 SYNGAP1 MET SCN8A TMEM266 PLCB4 TACR3 MME ADCY4 NSF GRID2 NR3C1 RGS7 CASK CNNM4 MTOR DNM3 MARK2 | 3.64e-04 | 858 | 239 | 22 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | DAB2IP KIF21B PDE2A SNAP47 ITPR1 SYNGAP1 MET SCN8A TMEM266 PLCB4 TACR3 MME ADCY4 NSF GRID2 NR3C1 RGS7 CASK CNNM4 MTOR DNM3 MARK2 | 3.76e-04 | 860 | 239 | 22 | GO:0097447 |
| GeneOntologyCellularComponent | radial spoke stalk | 3.88e-04 | 3 | 239 | 2 | GO:0001536 | |
| GeneOntologyCellularComponent | radial spoke | 6.07e-04 | 15 | 239 | 3 | GO:0001534 | |
| GeneOntologyCellularComponent | sperm flagellum | 8.28e-04 | 214 | 239 | 9 | GO:0036126 | |
| GeneOntologyCellularComponent | actin cytoskeleton | NCKAP1 ACTBL2 APC2 ACTA1 ACTA2 ACTC1 ACTG2 LANCL2 KAT2B SVIL CDC42BPB ACTR2 CASK ARHGAP6 MICAL2 MARK2 | 1.02e-03 | 576 | 239 | 16 | GO:0015629 |
| GeneOntologyCellularComponent | lamellipodium membrane | 1.94e-03 | 22 | 239 | 3 | GO:0031258 | |
| GeneOntologyCellularComponent | lipid droplet | 2.19e-03 | 116 | 239 | 6 | GO:0005811 | |
| Domain | ACTINS_1 | 1.64e-08 | 8 | 235 | 5 | PS00406 | |
| Domain | Actin/actin-like_CS | 6.09e-08 | 18 | 235 | 6 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 8.81e-08 | 19 | 235 | 6 | PS01132 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.52e-07 | 14 | 235 | 5 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 5.52e-07 | 14 | 235 | 5 | IPR013602 | |
| Domain | DHC_N2 | 5.52e-07 | 14 | 235 | 5 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 5.52e-07 | 14 | 235 | 5 | IPR011704 | |
| Domain | AAA_8 | 5.52e-07 | 14 | 235 | 5 | PF12780 | |
| Domain | AAA_5 | 5.52e-07 | 14 | 235 | 5 | PF07728 | |
| Domain | DHC_fam | 8.19e-07 | 15 | 235 | 5 | IPR026983 | |
| Domain | Dynein_heavy | 8.19e-07 | 15 | 235 | 5 | PF03028 | |
| Domain | Dynein_heavy_dom | 8.19e-07 | 15 | 235 | 5 | IPR004273 | |
| Domain | Actin_CS | 1.18e-06 | 16 | 235 | 5 | IPR004001 | |
| Domain | ACTINS_2 | 1.65e-06 | 17 | 235 | 5 | PS00432 | |
| Domain | Actin | 2.11e-06 | 31 | 235 | 6 | IPR004000 | |
| Domain | Actin | 2.11e-06 | 31 | 235 | 6 | PF00022 | |
| Domain | ACTIN | 2.11e-06 | 31 | 235 | 6 | SM00268 | |
| Domain | RCC1 | 4.02e-06 | 20 | 235 | 5 | PF00415 | |
| Domain | RCC1_1 | 5.22e-06 | 21 | 235 | 5 | PS00625 | |
| Domain | RCC1_2 | 5.22e-06 | 21 | 235 | 5 | PS00626 | |
| Domain | RCC1_3 | 5.22e-06 | 21 | 235 | 5 | PS50012 | |
| Domain | ARM-type_fold | DOCK11 NBEAL1 IFT172 APC2 CUL7 TRRAP ITPR1 DOCK1 UBQLN1 COPG1 DOCK8 ARMC12 MROH2A AP3B1 MTOR WDFY3 | 6.59e-06 | 339 | 235 | 16 | IPR016024 |
| Domain | - | 6.68e-06 | 22 | 235 | 5 | 2.130.10.30 | |
| Domain | Reg_chr_condens | 6.68e-06 | 22 | 235 | 5 | IPR000408 | |
| Domain | TPR-like_helical_dom | SPAG1 IFT172 TTC21A NAPG TRRAP TRANK1 EIF3L ANAPC7 TTC28 GPS1 AAR2 TTC7A MTOR | 8.43e-06 | 233 | 235 | 13 | IPR011990 |
| Domain | RCC1/BLIP-II | 8.45e-06 | 23 | 235 | 5 | IPR009091 | |
| Domain | Dynein_HC_stalk | 2.21e-05 | 14 | 235 | 4 | IPR024743 | |
| Domain | MT | 2.21e-05 | 14 | 235 | 4 | PF12777 | |
| Domain | Kinase-like_dom | CHKB MAST2 TRRAP MET PTPN13 SYK PAK5 CDC42BPB CASK TGFBR1 LIMK1 MTOR NEK8 DNM3 PRKG2 MARK2 MAP2K3 ULK2 MAP3K2 | 5.95e-05 | 542 | 235 | 19 | IPR011009 |
| Domain | - | SPAG1 TTC21A NAPG TRRAP TRANK1 EIF3L ANAPC7 TTC28 GPS1 TTC7A MTOR | 6.52e-05 | 207 | 235 | 11 | 1.25.40.10 |
| Domain | AAA | 8.85e-05 | 144 | 235 | 9 | SM00382 | |
| Domain | AAA+_ATPase | 8.85e-05 | 144 | 235 | 9 | IPR003593 | |
| Domain | DHC_N1 | 1.05e-04 | 8 | 235 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.05e-04 | 8 | 235 | 3 | IPR013594 | |
| Domain | DHR-1_domain | 3.01e-04 | 11 | 235 | 3 | IPR027007 | |
| Domain | DHR_2 | 3.01e-04 | 11 | 235 | 3 | PS51651 | |
| Domain | DHR_1 | 3.01e-04 | 11 | 235 | 3 | PS51650 | |
| Domain | DHR-2 | 3.01e-04 | 11 | 235 | 3 | PF06920 | |
| Domain | DOCK | 3.01e-04 | 11 | 235 | 3 | IPR026791 | |
| Domain | DOCK_C | 3.01e-04 | 11 | 235 | 3 | IPR010703 | |
| Domain | DOCK-C2 | 3.01e-04 | 11 | 235 | 3 | PF14429 | |
| Domain | DHR-2 | 3.01e-04 | 11 | 235 | 3 | IPR027357 | |
| Domain | PH_dom-like | DAB2IP DOCK11 NBEAL1 SYNGAP1 PTPN13 PTPN14 PLCB4 PLEKHA8 ADAP1 MTMR8 ECT2L CDC42BPB MTMR7 DNM3 WDFY3 | 3.42e-04 | 426 | 235 | 15 | IPR011993 |
| Domain | DUF3498 | 4.69e-04 | 3 | 235 | 2 | IPR021887 | |
| Domain | - | 4.69e-04 | 3 | 235 | 2 | 1.10.238.110 | |
| Domain | DAG_kinase_N | 4.69e-04 | 3 | 235 | 2 | PF14513 | |
| Domain | DAG_kinase_typeI_N | 4.69e-04 | 3 | 235 | 2 | IPR029477 | |
| Domain | DUF3498 | 4.69e-04 | 3 | 235 | 2 | PF12004 | |
| Domain | TPR_8 | 5.30e-04 | 53 | 235 | 5 | PF13181 | |
| Domain | Ion_trans_dom | 6.00e-04 | 114 | 235 | 7 | IPR005821 | |
| Domain | Ion_trans | 6.00e-04 | 114 | 235 | 7 | PF00520 | |
| Domain | Cyt_P450_E_grp-I_CYP2A-like | 9.30e-04 | 4 | 235 | 2 | IPR008067 | |
| Domain | SHR-BD | 9.30e-04 | 4 | 235 | 2 | IPR009543 | |
| Domain | VPS13_C | 9.30e-04 | 4 | 235 | 2 | PF16909 | |
| Domain | VPS13_C | 9.30e-04 | 4 | 235 | 2 | IPR031645 | |
| Domain | SHR-BD | 9.30e-04 | 4 | 235 | 2 | PF06650 | |
| Domain | TPR_REGION | 1.18e-03 | 165 | 235 | 8 | PS50293 | |
| Domain | TPR | 1.18e-03 | 165 | 235 | 8 | PS50005 | |
| Domain | - | NAIP TRANK1 SULT2A1 SUPV3L1 MOV10L1 TOR3A DNAH8 DNAH9 DYNC1H1 DNAH3 ARL16 NSF ABCF2 NLRP2 CASK ABCG1 DNAH12 SMC3 DNM3 HYDIN | 1.24e-03 | 746 | 235 | 20 | 3.40.50.300 |
| Domain | - | DAB2IP DOCK11 SYNGAP1 PTPN13 PTPN14 PLCB4 PLEKHA8 ADAP1 MTMR8 ECT2L CDC42BPB MTMR7 DNM3 | 1.42e-03 | 391 | 235 | 13 | 2.30.29.30 |
| Domain | Autophagy-rel_C | 1.54e-03 | 5 | 235 | 2 | IPR015412 | |
| Domain | ATG_C | 1.54e-03 | 5 | 235 | 2 | PF09333 | |
| Domain | DUF4704 | 1.54e-03 | 5 | 235 | 2 | IPR031570 | |
| Domain | DUF4704 | 1.54e-03 | 5 | 235 | 2 | PF15787 | |
| Domain | Ser/Thr_kinase_AS | MAST2 PAK5 CDC42BPB CASK TGFBR1 LIMK1 NEK8 PRKG2 MARK2 MAP2K3 ULK2 MAP3K2 | 1.96e-03 | 357 | 235 | 12 | IPR008271 |
| Domain | PROTEIN_KINASE_ATP | MAST2 MET SYK PAK5 CDC42BPB CASK TGFBR1 LIMK1 NEK8 PRKG2 MARK2 MAP2K3 ULK2 MAP3K2 | 2.11e-03 | 459 | 235 | 14 | PS00107 |
| Domain | PROTEIN_KINASE_ST | MAST2 PAK5 CDC42BPB CASK TGFBR1 LIMK1 NEK8 PRKG2 MARK2 MAP2K3 ULK2 MAP3K2 | 2.20e-03 | 362 | 235 | 12 | PS00108 |
| Domain | PH_BEACH | 2.29e-03 | 6 | 235 | 2 | PF14844 | |
| Domain | DUF3398 | 2.29e-03 | 6 | 235 | 2 | PF11878 | |
| Domain | FAT | 2.29e-03 | 6 | 235 | 2 | PS51189 | |
| Domain | FATC | 2.29e-03 | 6 | 235 | 2 | PS51190 | |
| Domain | FAT | 2.29e-03 | 6 | 235 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 2.29e-03 | 6 | 235 | 2 | IPR003151 | |
| Domain | FATC_dom | 2.29e-03 | 6 | 235 | 2 | IPR003152 | |
| Domain | DOCK_C/D_N | 2.29e-03 | 6 | 235 | 2 | IPR021816 | |
| Domain | PIK_FAT | 2.29e-03 | 6 | 235 | 2 | IPR014009 | |
| Domain | FATC | 2.29e-03 | 6 | 235 | 2 | SM01343 | |
| Domain | ARM-like | 2.29e-03 | 270 | 235 | 10 | IPR011989 | |
| Domain | P-loop_NTPase | KIF21B NAIP TRANK1 SULT2A1 SUPV3L1 MOV10L1 TOR3A DNAH8 DNAH9 DYNC1H1 DNAH3 ARL16 NSF ABCF2 NLRP2 CASK ABCG1 DNAH12 SMC3 DNM3 HYDIN | 2.47e-03 | 848 | 235 | 21 | IPR027417 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 2.29e-05 | 27 | 184 | 5 | M47755 | |
| Pathway | WP_RETT_SYNDROME | 3.55e-05 | 48 | 184 | 6 | M39759 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DAB2IP SPAG1 NCKAP1 MYCBP2 IFT172 TTC21A ACTBL2 CDH23 ANKLE2 SNAP47 CNOT6 ACSL3 PTPN13 PTPN14 EIF3L METTL25 QARS1 ANAPC7 DYNC1H1 CFAP91 RPGRIP1L NSF IFT81 GPS1 LARS1 SNX33 AP3B1 AAR2 CNNM4 SH2D4A SMC3 MTOR EIF2B1 NEK8 PRKG2 MARK2 RPA2 HDAC1 MAP3K2 | 1.61e-14 | 1321 | 239 | 39 | 27173435 |
| Pubmed | DAB2IP TPP2 MYCBP2 ACTBL2 BCKDK ACTA1 CUL7 ANKLE2 ITPR1 ACSL3 ACSL4 PTPN13 PTPN14 SVIL VPS13A USP7 DUSP18 RPGRIP1L CDKN2AIP MTMR8 CCT2 STAM AP3B1 CDC42BPB CASK CNNM4 MTMR7 SH2D4A NUP155 TSR1 PDP1 CEP135 AATF RPA2 | 6.84e-14 | 1049 | 239 | 34 | 27880917 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NCKAP1 CUL7 TRRAP ACSL4 TOR3A QARS1 ANAPC7 FOXG1 DYNC1H1 USP47 COPG1 NSF IFT81 LARS1 SLU7 RELB SNX33 NR3C1 JMJD1C CREB5 TGM1 FOXB1 SMC3 RPA2 MAP2K3 HERC5 | 3.08e-10 | 857 | 239 | 26 | 25609649 |
| Pubmed | CYP2A6 SPAG1 ACACB SLCO2B1 ACTBL2 ACTA1 ACTA2 ACTC1 DGKA ACTG2 ANKRD30B ANKLE2 ACSL3 ACSL4 SCN4A VPS13A METTL25 DNAH8 ANAPC7 CACNA1E ADAP1 PCDHGA7 IFT81 TAF1B GPS1 RBM42 ABCF2 CCT2 ACTR2 AAR2 TESMIN AATF HDAC1 MYBPC1 | 3.89e-10 | 1442 | 239 | 34 | 35575683 | |
| Pubmed | TPP2 ACTBL2 BCKDK ACTA2 NAPG COG3 SUCLA2 SNAP47 NDUFB10 ITPR1 NCBP3 EVI5 ACSL3 FAF2 ALG5 EIF3L USP7 QARS1 DYNC1H1 COPG1 NSF LARS1 ABCF2 CCT2 RELB ACTR2 CNNM4 NUP155 MTOR AASS EIF2B1 RPA2 HERC5 | 1.48e-09 | 1440 | 239 | 33 | 30833792 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | NCKAP1 MYCBP2 BCKDK MAST2 TRRAP MET FAF2 EIF3L USP7 DYNC1H1 COPG1 NSF PAK5 GPS1 LARS1 LCN1 AP3B1 CDC42BPB PRPF40A JMJD1C ACTR2 CNNM4 IBTK SH2D4A SMC3 TSR1 EIF2B1 CEP135 MARK2 MAP3K2 | 5.71e-09 | 1284 | 239 | 30 | 17353931 |
| Pubmed | N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. | 6.57e-09 | 11 | 239 | 5 | 23294842 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | ACTA1 ACTA2 ACTC1 ACTG2 ITPR1 SVIL EIF3L USP7 DYNC1H1 COPG1 LARS1 ABCF2 CCT2 PRPF40A ACTR2 TGM1 NUP155 SMC3 TSR1 EIF2B1 AATF MARK2 MAP2K3 HERC5 HDAC1 | 1.16e-08 | 949 | 239 | 25 | 36574265 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | KIF21B ACACB NCKAP1 DOCK11 TRRAP NCBP3 SYNGAP1 TRANK1 USP7 PLCB4 QARS1 CDKN2AIP IFT81 GPS1 DNAH12 SMC3 MARK2 HYDIN | 1.31e-08 | 497 | 239 | 18 | 36774506 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NCKAP1 MAST2 SUCLA2 LANCL2 ACSL3 FAF2 SUPV3L1 EIF3L USP7 QARS1 ANAPC7 PHIP DYNC1H1 TMEM117 ADCY4 COPG1 NSF LARS1 ABCF2 CCT2 AP3B1 PRPF40A ACTR2 NUP155 SMC3 TSR1 MTOR EIF2B1 RPA2 HDAC1 MYBPC1 | 1.62e-08 | 1425 | 239 | 31 | 30948266 |
| Pubmed | DOCK11 ACTA1 PTPN14 FAF2 USP7 QARS1 DYNC1H1 USP47 UBQLN1 NSF CDKN2AIP LARS1 NUP155 SMC3 TSR1 HDAC1 | 2.12e-08 | 399 | 239 | 16 | 37536630 | |
| Pubmed | 2.80e-08 | 14 | 239 | 5 | 21923909 | ||
| Pubmed | 2.80e-08 | 14 | 239 | 5 | 9373155 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ACACB NCKAP1 BCKDK MAST2 ANKLE2 LRP1B RBSN KLHL9 PTPN14 SVIL DYNC1H1 USP47 FAM184A RPGRIP1L TTC28 IFT81 CCT2 IBTK SH2D4A TSR1 AASS SLC25A15 CEP135 | 3.04e-08 | 853 | 239 | 23 | 28718761 |
| Pubmed | Virus assembly and plasma membrane domains: which came first? | 3.23e-08 | 6 | 239 | 4 | 22989508 | |
| Pubmed | 3.23e-08 | 6 | 239 | 4 | 12009869 | ||
| Pubmed | HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury. | 3.23e-08 | 6 | 239 | 4 | 23811015 | |
| Pubmed | Retroviral assembly and budding occur through an actin-driven mechanism. | 3.23e-08 | 6 | 239 | 4 | 19883584 | |
| Pubmed | Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. | 3.23e-08 | 6 | 239 | 4 | 21917091 | |
| Pubmed | HIV-1 Gag protein associates with F-actin present in microfilaments. | 3.23e-08 | 6 | 239 | 4 | 8661406 | |
| Pubmed | 3.23e-08 | 6 | 239 | 4 | 23017337 | ||
| Pubmed | 3.23e-08 | 6 | 239 | 4 | 9841925 | ||
| Pubmed | Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. | 3.23e-08 | 6 | 239 | 4 | 9971772 | |
| Pubmed | Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. | 3.23e-08 | 6 | 239 | 4 | 10074138 | |
| Pubmed | HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. | 3.23e-08 | 6 | 239 | 4 | 1540415 | |
| Pubmed | HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. | 3.23e-08 | 6 | 239 | 4 | 11709093 | |
| Pubmed | 3.23e-08 | 6 | 239 | 4 | 10049817 | ||
| Pubmed | Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens. | 3.23e-08 | 6 | 239 | 4 | 23875777 | |
| Pubmed | TPP2 NCKAP1 MYCBP2 CUL7 TRRAP ACSL3 EIF3L USP7 PHIP DYNC1H1 USP47 COPG1 CCT2 PRPF40A ACTR2 NUP155 TSR1 MTOR AATF HERC5 | 3.26e-08 | 653 | 239 | 20 | 22586326 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | ZNHIT3 ITPR1 CNOT6 FBXO28 SVIL EIF3L ANAPC7 DYNC1H1 USP47 RETREG2 COPG1 POGK CDKN2AIP GPS1 BUD13 CCT2 LCN1 AAR2 TGM1 SH2D4A NUP155 SMC3 TSR1 CEP135 MARK2 RPA2 VPS13B | 3.48e-08 | 1155 | 239 | 27 | 20360068 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MYCBP2 ACTBL2 BCKDK CUL7 SUCLA2 ANKLE2 SNAP47 NDUFB10 ITPR1 ACSL3 ACSL4 PTPN14 FAF2 SUPV3L1 FBXO28 VPS13A ANAPC7 PHIP USP47 RPGRIP1L TTC28 CCT2 ACTR2 CASK IBTK NUP155 AASS AATF MARK2 RPA2 VPS13B | 4.85e-08 | 1496 | 239 | 31 | 32877691 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | TPP2 MYCBP2 BCKDK SUCLA2 ACSL3 PTPN13 ALG5 EIF3L USP7 COPG1 NSF SLU7 AP3B1 AAR2 IBTK MTOR AASS EIF2B1 CEP135 AATF MARK2 | 7.28e-08 | 754 | 239 | 21 | 33060197 |
| Pubmed | 7.49e-08 | 7 | 239 | 4 | 22535526 | ||
| Pubmed | HIV-1 replication from after cell entry to the nuclear periphery. | 7.49e-08 | 7 | 239 | 4 | 17504171 | |
| Pubmed | Selective targeting of ITK blocks multiple steps of HIV replication. | 7.49e-08 | 7 | 239 | 4 | 18443296 | |
| Pubmed | The trinity of the cortical actin in the initiation of HIV-1 infection. | 7.49e-08 | 7 | 239 | 4 | 22640593 | |
| Pubmed | 7.49e-08 | 7 | 239 | 4 | 22465675 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MYCBP2 BCKDK KCTD1 CUL7 TRRAP NCBP3 QARS1 TAF1B LARS1 SLU7 BUD13 ABCF2 IBTK NUP155 SMC3 TSR1 EIF2B1 AATF MARK2 HERC5 HDAC1 | 8.13e-08 | 759 | 239 | 21 | 35915203 |
| Pubmed | ACACB NCKAP1 DOCK11 ACTA1 CUL7 MAST2 ACSL3 PTPN13 PTPN14 QARS1 TTC28 DOCK8 STAM SMC3 MARK2 MAP3K2 | 9.78e-08 | 446 | 239 | 16 | 24255178 | |
| Pubmed | NCKAP1 ANKLE2 LANCL2 PTPN13 QARS1 DYNC1H1 DOCK1 TTC28 NSF LARS1 ABCF2 CCT2 STAM AP3B1 PRPF40A JMJD1C NUP155 SMC3 MARK2 HDAC1 | 1.20e-07 | 708 | 239 | 20 | 39231216 | |
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 1.37e-07 | 118 | 239 | 9 | 27377895 | |
| Pubmed | MYCBP2 BCKDK SUCLA2 ANKLE2 SNAP47 NDUFB10 ITPR1 NCBP3 ACSL3 MET PTPN13 PTPN14 FAF2 VPS13A FAM184A NSF IFT81 SLU7 NR3C1 AP3B1 CDC42BPB PRPF40A AAR2 CASK NUP155 TSR1 SLC25A15 MARK2 VPS13B HERC5 | 1.45e-07 | 1487 | 239 | 30 | 33957083 | |
| Pubmed | 1.49e-07 | 8 | 239 | 4 | 20147394 | ||
| Pubmed | 1.49e-07 | 8 | 239 | 4 | 23260110 | ||
| Pubmed | 1.49e-07 | 8 | 239 | 4 | 14694110 | ||
| Pubmed | TPP2 PRMT8 SUCLA2 LANCL2 NDUFB10 ACSL3 ACSL4 FAF2 EIF3L ANAPC7 DYNC1H1 USP47 COPG1 NSF GPS1 LARS1 ABCF2 CCT2 NR3C1 NUP155 RPA2 DGAT1 | 2.17e-07 | 878 | 239 | 22 | 37223481 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NCKAP1 MYCBP2 TRRAP ACSL3 ACSL4 PTPN14 FAF2 SUPV3L1 EIF3L USP7 QARS1 PHIP DYNC1H1 COPG1 TAF1B LARS1 SLU7 ABCF2 CCT2 SNX33 AAR2 TGM1 NUP155 SMC3 MICAL2 AATF WDFY3 MAP2K3 | 2.35e-07 | 1353 | 239 | 28 | 29467282 |
| Pubmed | Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. | 2.67e-07 | 9 | 239 | 4 | 10556093 | |
| Pubmed | Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. | 2.67e-07 | 9 | 239 | 4 | 8892894 | |
| Pubmed | 2.67e-07 | 9 | 239 | 4 | 18775311 | ||
| Pubmed | PDE2A MYCBP2 ADAM23 IFT172 APC2 ZNF189 LRP1B SYNGAP1 PTPN13 SUPV3L1 USP7 QARS1 DYNC1H1 USP47 CFAP91 UBQLN1 TTC28 IFT81 LARS1 CCT2 STAM CDC42BPB CASK LIMK1 MICAL2 DNM3 WDFY3 | 2.92e-07 | 1285 | 239 | 27 | 35914814 | |
| Pubmed | Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization. | 3.20e-07 | 3 | 239 | 3 | 7780165 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 11960914 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | ACACB NCBP3 ACSL4 FBXO28 ANAPC7 DYNC1H1 SLU7 NR3C1 NUP155 TSR1 AATF ELF4 MARK2 HDAC1 | 3.32e-07 | 370 | 239 | 14 | 22922362 |
| Pubmed | 4.42e-07 | 10 | 239 | 4 | 1907279 | ||
| Pubmed | Non-viral cellular substrates for human immunodeficiency virus type 1 protease. | 4.42e-07 | 10 | 239 | 4 | 1991513 | |
| Pubmed | 4.42e-07 | 10 | 239 | 4 | 23575248 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | KIF21B PRMT8 SLCO2B1 CDH23 MAST2 TRRAP SNAP47 CNOT6 EVI5 ACSL4 RBSN KAT2B SUPV3L1 VPS13A ADAP1 RPGRIP1L COPG1 LARS1 SLU7 JMJD1C SMC3 MTOR DNAH17 CFAP61 GPRC5B HDAC1 | 5.28e-07 | 1242 | 239 | 26 | 30973865 |
| Pubmed | WDR64 ACACB ITPKB ACSL4 FAF2 VPS13A HERC6 USP47 TTC28 SLU7 NR3C1 AP3B1 PRDM5 USP6 DNAH12 AASS AATF WDFY3 | 5.36e-07 | 638 | 239 | 18 | 31182584 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | MYCBP2 ACTA1 ACTA2 ACTC1 ACTG2 SUCLA2 NDUFB10 ACSL3 KLHL9 FAF2 USP7 QARS1 ANAPC7 DYNC1H1 COPG1 NSF LARS1 ABCF2 CCT2 ACTR2 AAR2 NUP155 SMC3 AASS RPA2 HDAC1 | 6.60e-07 | 1257 | 239 | 26 | 37317656 |
| Pubmed | 6.91e-07 | 11 | 239 | 4 | 30962377 | ||
| Pubmed | Quantitative proteomic analysis of lentiviral vectors using 2-DE. | 6.91e-07 | 11 | 239 | 4 | 19639585 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | BID SUPV3L1 ANAPC7 DYNC1H1 DOCK1 COPG1 NSF DOCK8 CDKN2AIP CCT2 AP3B1 PRPF40A ACTR2 NUP155 SMC3 MARK2 MAP2K3 | 6.96e-07 | 582 | 239 | 17 | 20467437 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | NCKAP1 ANKLE2 NDUFB10 ACSL3 FAF2 ALG5 EIF3L QARS1 DYNC1H1 UBQLN1 COPG1 NSF GPS1 LARS1 ABCF2 LCN1 AP3B1 AAR2 CNNM4 NUP155 SMC3 MTOR | 7.05e-07 | 942 | 239 | 22 | 31073040 |
| Pubmed | TPP2 PDE2A NCKAP1 TTC21A ACTBL2 ACTA1 SUCLA2 SNAP47 LANCL2 ITPKB SYNGAP1 SVIL EIF3L USP7 DYNC1H1 ADCY4 NSF DOCK8 LARS1 CCT2 AP3B1 CDC42BPB PRPF40A ACTR2 CASK TGM1 MICAL2 MARK2 | 7.16e-07 | 1431 | 239 | 28 | 37142655 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYCBP2 ACTBL2 ACTA1 ACTC1 CUL7 TRRAP NCBP3 ACSL3 SVIL QARS1 ANAPC7 PHIP DYNC1H1 NSF LARS1 ABCF2 CCT2 PRPF40A ACTR2 NUP155 SMC3 AATF MARK2 | 7.60e-07 | 1024 | 239 | 23 | 24711643 |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | TPP2 ACACB ACTA1 ACTA2 SUCLA2 ACSL4 DYNC1H1 COPG1 NSF LARS1 ABCF2 CCT2 AP3B1 PRPF40A JMJD1C ACTR2 NUP155 HDAC1 | 9.68e-07 | 665 | 239 | 18 | 30457570 |
| Pubmed | 1.03e-06 | 12 | 239 | 4 | 23071112 | ||
| Pubmed | TPP2 NCKAP1 MYCBP2 TRRAP LANCL2 CNOT6 ACSL3 MET EIF3L PLCB4 TOR3A QARS1 DYNC1H1 UBQLN1 COPG1 LARS1 CCT2 RELB STAM CDC42BPB ACTR2 NUP155 SMC3 TSR1 RPA2 HDAC1 | 1.18e-06 | 1297 | 239 | 26 | 33545068 | |
| Pubmed | The splicing regulator SLU7 is required to preserve DNMT1 protein stability and DNA methylation. | 1.28e-06 | 4 | 239 | 3 | 34331453 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | KIF21B PDE2A NCKAP1 NAIP NAPG DGKA SUCLA2 TRRAP LANCL2 ITPR1 DYNC1H1 NSF DOCK8 GRID2 CCT2 MTOR MARK2 | 1.68e-06 | 621 | 239 | 17 | 22794259 |
| Pubmed | NCKAP1 ACTBL2 BCKDK TRRAP CNOT6 PWWP2A PTPN13 FBXO28 EIF3L USP7 TMEM266 ANAPC7 FAM184A UBQLN1 NSF CDKN2AIP RBM42 BUD13 ABCF2 ECT2L AP3B1 CDC42BPB CASK TSR1 AATF MARK2 DGAT1 HDAC1 | 1.72e-06 | 1497 | 239 | 28 | 31527615 | |
| Pubmed | 2.06e-06 | 14 | 239 | 4 | 17411366 | ||
| Pubmed | MYCBP2 ACTBL2 SUCLA2 FAF2 VPS13A PHIP CDKN2AIP IFT81 ABCF2 CDC42BPB | 2.08e-06 | 209 | 239 | 10 | 26389662 | |
| Pubmed | NCKAP1 IFT172 FAF2 EIF3L USP7 QARS1 DYNC1H1 COPG1 NSF GPS1 LARS1 CCT2 AP3B1 NUP155 SMC3 MTOR HDAC1 | 2.41e-06 | 638 | 239 | 17 | 33239621 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | DAB2IP SPAG1 SLCO2B1 MET PTPN14 ELMOD3 SLITRK6 CDC42BPB CASK TGM1 SH2D4A MTOR MICAL2 MARK2 VPS13B GPRC5B | 2.43e-06 | 569 | 239 | 16 | 30639242 |
| Pubmed | 4.82e-06 | 17 | 239 | 4 | 17360745 | ||
| Pubmed | 4.82e-06 | 17 | 239 | 4 | 8997639 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ACACB ACTC1 GMEB2 SUCLA2 ALG5 EIF3L QARS1 PHIP DYNC1H1 COPG1 NSF CDKN2AIP LARS1 ABCF2 CCT2 AP3B1 PRPF40A ACTR2 SMC3 TSR1 SLC25A15 AATF RPA2 MAP2K3 HDAC1 | 5.04e-06 | 1318 | 239 | 25 | 30463901 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | NCKAP1 MYCBP2 ACTBL2 ACTA2 ACTC1 SVIL EIF3L USP7 QARS1 ANAPC7 DYNC1H1 COPG1 NSF LARS1 CCT2 NR3C1 AP3B1 PRPF40A ACTR2 SMC3 TSR1 RPA2 HDAC1 | 5.18e-06 | 1149 | 239 | 23 | 35446349 |
| Pubmed | DAB2IP NCKAP1 IFT172 FAF2 FBXO28 DYNC1H1 TTC28 POGK BTBD7 DNM3 PPIP5K1 ULK2 VPS13B | 5.63e-06 | 407 | 239 | 13 | 12693553 | |
| Pubmed | LANCL2 ACSL3 FAF2 DYNC1H1 LARS1 ABCF2 ACTR2 NUP155 SMC3 HDAC1 | 6.34e-06 | 237 | 239 | 10 | 29564676 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYCBP2 SUCLA2 TRRAP LANCL2 KLHL9 FAF2 EIF3L USP7 ANAPC7 USP47 TTC28 COPG1 NSF TAF1B GPS1 RBM42 CASK USP6 NUP155 SMC3 MARK2 | 7.12e-06 | 1005 | 239 | 21 | 19615732 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | KIF21B TPP2 NCKAP1 ACTA2 ACTC1 EIF3L QARS1 DYNC1H1 DNAH3 LARS1 ABCF2 CCT2 AP3B1 PRPF40A ACTR2 SMC3 DNM3 MAP2K3 HDAC1 | 7.36e-06 | 847 | 239 | 19 | 35235311 |
| Pubmed | 7.77e-06 | 19 | 239 | 4 | 12721789 | ||
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | MYCBP2 BCKDK ACSL3 ALG5 SLU7 AP3B1 AAR2 MTOR AASS CEP135 AATF | 7.80e-06 | 298 | 239 | 11 | 32353859 |
| Pubmed | DAB2IP ACACB ANKLE2 SNAP47 MET RBSN PTPN13 PTPN14 STAM RGS7 CASK NUP155 MARK2 | 8.09e-06 | 421 | 239 | 13 | 36976175 | |
| Pubmed | ACACB SNAP47 MET RBSN PTPN13 FAF2 VPS13A DYNC1H1 PLEKHA8 ARL16 RPGRIP1L TTC28 COPG1 CCT2 AP3B1 CDC42BPB CASK NUP155 | 8.36e-06 | 777 | 239 | 18 | 35844135 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | TTC21A BCKDK ACTA2 SUCLA2 ANKLE2 NDUFB10 ITPR1 ACSL3 ACSL4 PTPN14 FAF2 ALG5 TOR3A FAM184A COPG1 NSF ABCF2 CCT2 SNX33 PRPF40A ACTR2 CREB5 NUP155 GLCE SLC25A15 HDAC1 | 8.83e-06 | 1451 | 239 | 26 | 30550785 |
| Pubmed | NCKAP1 ACSL3 ALG5 ANAPC7 DYNC1H1 COPG1 IFT81 GPS1 RBM42 AP3B1 AAR2 CASK NUP155 SMC3 HDAC1 | 8.97e-06 | 560 | 239 | 15 | 35241646 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ACACB APC2 SYNGAP1 FAF2 USP7 DYNC1H1 DOCK1 TSHZ3 UBQLN1 RELB ARHGAP6 NUP155 GPRC5B | 1.01e-05 | 430 | 239 | 13 | 35044719 |
| Pubmed | ACTA1 ACTA2 ACTC1 ACTG2 COG3 SUCLA2 ANKLE2 SNAP47 ACSL3 PTPN13 FAF2 ALG5 EIF3L PLEKHA8 STAM ACTR2 CNNM4 NUP155 SMC3 MARK2 | 1.10e-05 | 952 | 239 | 20 | 38569033 | |
| Pubmed | Human ING1 proteins differentially regulate histone acetylation. | 1.10e-05 | 7 | 239 | 3 | 12015309 | |
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 9256245 | ||
| Pubmed | Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. | 1.10e-05 | 7 | 239 | 3 | 9384381 | |
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 30289203 | ||
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 31178125 | ||
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 18535780 | ||
| Pubmed | Myocardial Mycn is essential for mouse ventricular wall morphogenesis. | 1.19e-05 | 21 | 239 | 4 | 23063798 | |
| Pubmed | ACSL3 ACSL4 FAF2 SVIL DYNC1H1 COPG1 NSF LARS1 ABCF2 TGM1 MTOR | 1.20e-05 | 312 | 239 | 11 | 37120454 | |
| Interaction | MOB3C interactions | DOCK11 ACTA1 PTPN14 FAF2 USP7 QARS1 DYNC1H1 USP47 UBQLN1 NSF CDKN2AIP LARS1 NUP155 SMC3 TSR1 HDAC1 | 6.29e-06 | 364 | 235 | 16 | int:MOB3C |
| Interaction | HECTD1 interactions | MYCBP2 BCKDK KCTD1 CUL7 TRRAP ZNHIT3 NCBP3 PTPN14 QARS1 RPGRIP1L TTC28 ARMC12 TAF1B LARS1 SLU7 BUD13 ABCF2 PRPF40A IBTK NUP155 SMC3 TSR1 EIF2B1 DNM3 AATF MARK2 HERC5 HDAC1 | 1.23e-05 | 984 | 235 | 28 | int:HECTD1 |
| Interaction | LYN interactions | DAB2IP TPP2 ZNF189 CDH23 SNAP47 ITPR1 ACSL3 MET PTPN13 PTPN14 FBXO28 SVIL VPS13A SYK MME PHIP CFAP91 CDC42BPB CASK SH2D4A TSR1 MARK2 RPA2 | 1.29e-05 | 720 | 235 | 23 | int:LYN |
| Interaction | PLEC interactions | ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 CUL7 ITPR1 NCBP3 USP7 QARS1 DNAH3 ARMC12 PAK5 ECT2L SMC3 RPA2 HDAC1 | 1.29e-05 | 430 | 235 | 17 | int:PLEC |
| Interaction | TAL1 interactions | 1.32e-05 | 93 | 235 | 8 | int:TAL1 | |
| Interaction | STIP1 interactions | NCKAP1 IFT172 BCKDK CUL7 SYNGAP1 PTPN14 FAF2 EIF3L USP7 QARS1 DYNC1H1 COPG1 NSF DOCK8 GPS1 MTMR8 LARS1 CCT2 AP3B1 ACTR2 AAR2 MTMR7 NUP155 SMC3 MTOR NEK8 RPA2 HDAC1 | 1.84e-05 | 1006 | 235 | 28 | int:STIP1 |
| Interaction | FBXO22 interactions | KIF21B ACACB NCKAP1 DOCK11 TRRAP NCBP3 SYNGAP1 TRANK1 USP7 PLCB4 QARS1 CDKN2AIP IFT81 GPS1 AAR2 DNAH12 SMC3 MARK2 HYDIN | 2.04e-05 | 540 | 235 | 19 | int:FBXO22 |
| Interaction | YWHAB interactions | DAB2IP KIF21B NCKAP1 MYCBP2 DOCK11 ACTA2 ACTC1 CUL7 MAST2 TRRAP ITPKB BID PTPN13 PTPN14 SVIL DYNC1H1 USP47 TTC28 PAK5 STAM RGS7 ACTR2 AAR2 MTOR AASS MARK2 RPA2 MAP3K2 | 2.12e-05 | 1014 | 235 | 28 | int:YWHAB |
| Interaction | ACTG2 interactions | 2.17e-05 | 49 | 235 | 6 | int:ACTG2 | |
| Interaction | PRKCD interactions | ACTBL2 BCKDK ACTA1 ACTA2 NCF4 ITPR1 DYNC1H1 BUD13 IBTK MTOR PDP1 RPA2 | 2.45e-05 | 238 | 235 | 12 | int:PRKCD |
| Interaction | SERBP1 interactions | TPP2 PRMT8 ACTC1 SUCLA2 TRRAP LANCL2 NDUFB10 SYNGAP1 ACSL3 ACSL4 KAT2B FAF2 SUPV3L1 EIF3L USP7 ANAPC7 DYNC1H1 USP47 COPG1 NSF GPS1 LARS1 RBM42 ABCF2 CCT2 NR3C1 PRPF40A AAR2 IBTK NUP155 TSR1 DNM3 RPA2 DGAT1 HERC5 | 2.50e-05 | 1432 | 235 | 35 | int:SERBP1 |
| Interaction | POTEJ interactions | 3.07e-05 | 52 | 235 | 6 | int:POTEJ | |
| Interaction | HOMER1 interactions | 3.99e-05 | 140 | 235 | 9 | int:HOMER1 | |
| Interaction | HUWE1 interactions | PDE2A ACACB NCKAP1 MYCBP2 IFT172 LANCL2 BID SYNGAP1 ACSL3 FAF2 EIF3L USP7 QARS1 ANAPC7 DYNC1H1 TRPA1 COPG1 NSF GPS1 LARS1 ABCF2 CCT2 FOXB1 MTMR7 NUP155 MARK2 RPA2 MAP2K3 HERC5 | 4.12e-05 | 1110 | 235 | 29 | int:HUWE1 |
| Interaction | NUDC interactions | IFT172 ANKRD30B CUL7 COG3 SYNGAP1 QARS1 DYNC1H1 LARS1 ACTR2 AAR2 MTMR7 NEK8 RPA2 HYDIN | 4.46e-05 | 337 | 235 | 14 | int:NUDC |
| Interaction | FOXP3 interactions | ACACB NCBP3 ACSL4 FBXO28 USP7 ANAPC7 DYNC1H1 SLU7 NR3C1 NUP155 SMC3 TSR1 AATF ELF4 MARK2 HDAC1 | 5.11e-05 | 432 | 235 | 16 | int:FOXP3 |
| Interaction | GJA1 interactions | ACTA2 ANKLE2 SNAP47 ACSL3 MET PTPN13 PTPN14 FAF2 SCN4A VPS13A USP7 COPG1 CCT2 STAM CDC42BPB CASK NUP155 MARK2 VPS13B | 5.76e-05 | 583 | 235 | 19 | int:GJA1 |
| Interaction | ABRA interactions | 5.80e-05 | 36 | 235 | 5 | int:ABRA | |
| Interaction | SMARCA2 interactions | DAB2IP ACTBL2 APC2 ACTC1 ACSL4 KAT2B FAM184A RELB NR3C1 TTC7A SMC3 ELF4 RPA2 HDAC1 | 5.93e-05 | 346 | 235 | 14 | int:SMARCA2 |
| Interaction | YWHAE interactions | DAB2IP KIF21B NCKAP1 MYCBP2 DOCK11 ACTA2 ACTC1 CUL7 MAST2 LANCL2 SYNGAP1 PTPN13 PTPN14 SVIL DYNC1H1 RPGRIP1L TTC28 DOCK8 PAK5 LARS1 SNX33 ACTR2 AAR2 CASK MTOR AASS EIF2B1 MARK2 RPA2 HDAC1 MAP3K2 | 6.38e-05 | 1256 | 235 | 31 | int:YWHAE |
| Interaction | CTTN interactions | MYCBP2 TTC21A ACTA1 ACTC1 DGKA MET SYK USP7 METTL25 ADAP1 PRPF40A ACTR2 AAR2 SH2D4A RPA2 MAP2K3 | 8.25e-05 | 450 | 235 | 16 | int:CTTN |
| Interaction | CENPF interactions | 9.33e-05 | 122 | 235 | 8 | int:CENPF | |
| Interaction | GLI1 interactions | 1.07e-04 | 159 | 235 | 9 | int:GLI1 | |
| Interaction | SATB2 interactions | 1.07e-04 | 159 | 235 | 9 | int:SATB2 | |
| Interaction | PLK1 interactions | DAB2IP MYCBP2 CUL7 TRRAP EVI5 KLHL9 PTPN14 USP7 ANAPC7 PAK5 NUP155 SMC3 MTOR CEP135 MPLKIP RPA2 MAP3K2 | 1.09e-04 | 510 | 235 | 17 | int:PLK1 |
| Interaction | CAP2 interactions | 1.19e-04 | 66 | 235 | 6 | int:CAP2 | |
| Cytoband | 22q13.33 | 4.60e-05 | 38 | 239 | 4 | 22q13.33 | |
| Cytoband | 9q22 | 1.27e-04 | 19 | 239 | 3 | 9q22 | |
| GeneFamily | Actins | 1.06e-07 | 6 | 168 | 4 | 929 | |
| GeneFamily | Dyneins, axonemal | 3.69e-07 | 17 | 168 | 5 | 536 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 7.19e-04 | 115 | 168 | 6 | 769 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCKAP1 MYCBP2 MAST2 ANKLE2 TRRAP ITPR1 EVI5 ACSL3 ACSL4 PTPN13 VPS13A USP7 PLCB4 PHIP DOCK1 TTC28 STAM NR3C1 AP3B1 RGS7 CREB5 CASK CEMIP USP6 IBTK SMC3 MICAL2 CEP135 WDFY3 VPS13B | 2.80e-10 | 856 | 238 | 30 | M4500 |
| Coexpression | WANG_LMO4_TARGETS_DN | ACTA2 ACSL3 FAF2 PTS FBXO28 DYNC1H1 USP47 UBQLN1 LARS1 ABCF2 AP3B1 PRPF40A ACTR2 CASK AATF | 1.23e-06 | 361 | 238 | 15 | M12674 |
| Coexpression | FORTSCHEGGER_PHF8_TARGETS_DN | RGMB NAPG ZNHIT3 CNOT6 KAT2B KLHL9 PTS VPS13A PLCB4 DUSP18 NSF PHOSPHO2 RELB CASK TGFBR1 TGM1 NUP155 MICAL2 MPLKIP ULK2 MAP3K2 | 1.07e-05 | 783 | 238 | 21 | M2488 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | RGMB MYCBP2 NBEAL1 NAPG ITPR1 VPS13A MME QARS1 PHIP DOCK1 DOCK8 SLU7 SENP8 ZFX TGFBR1 IBTK NUP155 | 1.05e-06 | 375 | 235 | 17 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | RGMB MYCBP2 NBEAL1 NAPG IRF6 ITPR1 MET PTS VPS13A SCN8A MME TOR3A QARS1 PHIP TMEM117 DOCK1 FAM184A DOCK8 SLU7 SENP8 ZFX TGFBR1 IBTK SH2D4A NUP155 | 1.76e-06 | 774 | 235 | 25 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | RGMB ADAM23 ACTA1 ACTA2 ACTC1 DGKA ACTG2 IRF6 MME SLITRK6 DOCK1 TTC28 GRID2 CEMIP TGFBR1 GPRC5B | 1.33e-05 | 407 | 235 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_1000 | SPAG1 MYCBP2 ACTC1 ACTG2 IRF6 ACSL3 MET FAT2 PTS VPS13A SCN8A PLCB4 TOR3A TMEM117 DOCK1 DOCK8 SENP8 ZFX TGFBR1 IBTK SH2D4A NUP155 MYBPC1 | 2.19e-05 | 784 | 235 | 23 | gudmap_developingLowerUrinaryTract_e15.5_urothelium_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_500 | RGMB MYCBP2 NBEAL1 NAPG IRF6 VPS13A SCN8A MME TOR3A QARS1 PHIP TMEM117 DOCK1 TGFBR1 IBTK | 3.20e-05 | 390 | 235 | 15 | gudmap_developingKidney_e15.5_cortic collect duct_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | RGMB MYCBP2 ADAM23 ACTA1 ACTA2 ACTC1 DGKA ACTG2 IRF6 PLCB4 MME SLITRK6 QARS1 DOCK1 TTC28 POGK SLU7 GRID2 ZFX CASK CEMIP TGFBR1 GPRC5B | 3.36e-05 | 806 | 235 | 23 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.33e-05 | 92 | 235 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 8.73e-05 | 163 | 235 | 9 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Control / Disease state, Lineage and Cell class | ACACB ACER3 DOCK11 SLCO2B1 EVI5 SVIL MME DOCK8 CDC42BPB ABCG1 | 8.13e-08 | 189 | 239 | 10 | 937e876122bc4b94372a4104e9c1a9068c232018 |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | ACACB ACER3 DOCK11 SLCO2B1 EVI5 SVIL MME DOCK8 CDC42BPB ABCG1 | 8.97e-08 | 191 | 239 | 10 | a7bb8aba9c59c037d995a77928cc7b4d5cbb82b9 |
| ToppCell | Ciliated-cil-3|World / Class top | IFT172 TTC21A CHKB CFAP206 DNAH9 DNAH3 CFAP91 RPGRIP1L CFAP61 HYDIN | 9.42e-08 | 192 | 239 | 10 | 4989ebb8812b8af1870599acd932849122c05a29 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SPAG1 TTC21A DNAH9 DNAH3 CFAP91 RPGRIP1L IFT81 ECT2L DNAH12 HYDIN | 1.04e-07 | 194 | 239 | 10 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | PRMT8 TTC21A DNAH9 DNAH3 FAM184A CFAP91 RPGRIP1L ECT2L DNAH12 HYDIN | 1.20e-07 | 197 | 239 | 10 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-07 | 160 | 239 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-07 | 160 | 239 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh|GI_large-bowel / Manually curated celltypes from each tissue | 2.55e-07 | 163 | 239 | 9 | 4104d3b9748b39cb0744c9be76db21bdda566a0d | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 7.39e-07 | 185 | 239 | 9 | 85cb81759589a26d83676cffbf2bc37399683c10 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | TTC21A CFAP206 DNAH9 DNAH3 CFAP91 RPGRIP1L IFT81 DNAH12 HYDIN | 8.46e-07 | 188 | 239 | 9 | 8f30535a32968a81a304315a49c0d90a77d36948 |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | TTC21A CFAP206 DNAH9 DNAH3 DUSP18 CFAP91 DNAH12 CFAP61 HYDIN | 8.84e-07 | 189 | 239 | 9 | b55de812043b670cbde810d7d42f45909b6d66ef |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.84e-07 | 189 | 239 | 9 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.84e-07 | 189 | 239 | 9 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | TTC21A CFAP206 DNAH9 DNAH3 DUSP18 CFAP91 DNAH12 CFAP61 HYDIN | 8.84e-07 | 189 | 239 | 9 | 4e83e49d1265ffe507fdb72924c77c4d1c73f0bd |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.65e-07 | 191 | 239 | 9 | bda8faf92495c8b362850c0aff4fc6fbdd9c563b | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.65e-07 | 191 | 239 | 9 | 6880fb348bb0915db9a5da4f3566ca9ff93ed258 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-06 | 192 | 239 | 9 | b5cdc2dae3154b1e4ade88f841f38584402ffe33 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-06 | 192 | 239 | 9 | 2d8d5a38e205339eda9c8aca1ca9ba3dcbe5ae56 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 1.15e-06 | 195 | 239 | 9 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.30e-06 | 198 | 239 | 9 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.30e-06 | 198 | 239 | 9 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.30e-06 | 198 | 239 | 9 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-06 | 199 | 239 | 9 | fde8e3ba19d19069a4d3b8db55bfe6220cf634d5 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-06 | 152 | 239 | 8 | 7a1072315cce71eefe2d32149a107d5648999968 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.89e-06 | 154 | 239 | 8 | 6c1e7682c43c40b58b371c58deb10b839700ebcc | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.51e-06 | 160 | 239 | 8 | 8624f101828efd32cdd38a65df8d94d690720a63 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.51e-06 | 160 | 239 | 8 | 9de3dd6b9d4b51314d60b3b01f4132bcfa2dfc18 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 3.45e-06 | 167 | 239 | 8 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.77e-06 | 169 | 239 | 8 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.31e-06 | 177 | 239 | 8 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-06 | 178 | 239 | 8 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.77e-06 | 179 | 239 | 8 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.26e-06 | 181 | 239 | 8 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 6.51e-06 | 182 | 239 | 8 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 7.34e-06 | 185 | 239 | 8 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.34e-06 | 185 | 239 | 8 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 7.64e-06 | 186 | 239 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 8.26e-06 | 188 | 239 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 8.26e-06 | 188 | 239 | 8 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 8.26e-06 | 188 | 239 | 8 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.26e-06 | 188 | 239 | 8 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.58e-06 | 189 | 239 | 8 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.58e-06 | 189 | 239 | 8 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | Epithelial-D_(Ciliated)|World / shred on cell class and cell subclass (v4) | 8.58e-06 | 189 | 239 | 8 | 0bf560b595c7a8450a46bc821b742b67965bd9f9 | |
| ToppCell | IPF-Myeloid-Macrophage_Alveolar|IPF / Disease state, Lineage and Cell class | 8.92e-06 | 190 | 239 | 8 | e539ebc0f4c5ee5dba86c614387be7d91338ad47 | |
| ToppCell | IPF-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 8.92e-06 | 190 | 239 | 8 | 2592765016f291565697265800a232b2edef3792 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.27e-06 | 191 | 239 | 8 | cadb7a9de16f4bb21606de0e25cddd2d748c7f0b | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 9.27e-06 | 191 | 239 | 8 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | CTRL-Myeloid-Alveolar_Macrophage|Myeloid / Disease state, Lineage and Cell class | 1.00e-05 | 193 | 239 | 8 | 80871d963c23a6befe58e5e60b7f7d1a1b227ce2 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 1.00e-05 | 193 | 239 | 8 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.00e-05 | 193 | 239 | 8 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 194 | 239 | 8 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.04e-05 | 194 | 239 | 8 | 69cf7c989ac355c459db13f9d4267b55adc3c174 | |
| ToppCell | Immune-alveolar_macrophage_(MARCO_positive)|World / Lineage, Cell type, age group and donor | 1.08e-05 | 195 | 239 | 8 | f92114ef995e690a3bedc62c89c5fd6773d0d9f7 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.08e-05 | 195 | 239 | 8 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.08e-05 | 195 | 239 | 8 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.08e-05 | 195 | 239 | 8 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 1.12e-05 | 196 | 239 | 8 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 1.12e-05 | 196 | 239 | 8 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | (05)_Ciliated|World / shred by cell type and Timepoint | 1.16e-05 | 197 | 239 | 8 | fee3cd16af8eea697cd64e8f64af505aaa2ac4b0 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 197 | 239 | 8 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 197 | 239 | 8 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 197 | 239 | 8 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 197 | 239 | 8 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-05 | 198 | 239 | 8 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-05 | 198 | 239 | 8 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 1.20e-05 | 198 | 239 | 8 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.25e-05 | 199 | 239 | 8 | 8e9862907b15809d083216e7d6a0f435015e5d15 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.25e-05 | 199 | 239 | 8 | 5b6feacb0ca92c3fc6b327be978320426dcf6f68 | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.25e-05 | 199 | 239 | 8 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-TRAM-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.29e-05 | 200 | 239 | 8 | 7c56935446f10d202eafa1f9ee7cb0aae4c2607e | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.29e-05 | 200 | 239 | 8 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.29e-05 | 200 | 239 | 8 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.29e-05 | 200 | 239 | 8 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.29e-05 | 200 | 239 | 8 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.29e-05 | 200 | 239 | 8 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.29e-05 | 200 | 239 | 8 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 1.76e-05 | 151 | 239 | 7 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.56e-05 | 160 | 239 | 7 | 70f3637dd0bcfcef421aa114f946fff0048f192e | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.24e-05 | 166 | 239 | 7 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l48|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.77e-05 | 170 | 239 | 7 | 070d8683d1a5cc7d594ff0453c961a9bf982c2d0 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 3.91e-05 | 171 | 239 | 7 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.91e-05 | 171 | 239 | 7 | fe0665c5ca01b0b2cc8f20d64587f0847c3d215c | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.37e-05 | 174 | 239 | 7 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.37e-05 | 174 | 239 | 7 | 42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.37e-05 | 174 | 239 | 7 | b6e3fa995def40a8fbdfc249fe108c303931a171 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.05e-05 | 178 | 239 | 7 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 178 | 239 | 7 | 5fc9f41609735b972a2cd0830182d13742cd5bf5 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-05 | 179 | 239 | 7 | 6eb84fe9691ad40127b2d1f1c672428333c8fab4 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-05 | 179 | 239 | 7 | 2c3abd646d2c8992e8ff76a824eab5beba8ba4c6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.23e-05 | 179 | 239 | 7 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-05 | 181 | 239 | 7 | 41969fe4d94ee77b12ecde32170aaf0b13e49644 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-05 | 181 | 239 | 7 | 3f50e61dc2a52d71a5801584617607e6246adcf2 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 5.61e-05 | 181 | 239 | 7 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-05 | 182 | 239 | 7 | 587636c0f127231de21acd8aa632b74ff22ca8c2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-05 | 182 | 239 | 7 | adfadd7893e74b3002f13f00875e3667d3493e0c | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 5.81e-05 | 182 | 239 | 7 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.81e-05 | 182 | 239 | 7 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 6.01e-05 | 183 | 239 | 7 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.01e-05 | 183 | 239 | 7 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| Drug | AC1L8FNU | 1.68e-08 | 44 | 239 | 8 | CID000425429 | |
| Drug | AC1OAGGW | ACTBL2 ACTA1 ACTA2 ACTC1 DGKA ACTG2 DGKG ITPR1 FIG4 PLCB4 PLEKHA8 MTOR DNM3 | 2.51e-07 | 203 | 239 | 13 | CID006857364 |
| Drug | AC1NQAAM | ACTA1 ACTA2 ACTC1 ACTG2 LCN1P1 COPG1 NSF RELB LCN1 MTOR AATF | 3.72e-07 | 144 | 239 | 11 | CID005192834 |
| Drug | manidipine | 7.14e-07 | 95 | 239 | 9 | CID000004008 | |
| Drug | Nsc687160 | 9.37e-07 | 18 | 239 | 5 | CID005459290 | |
| Drug | tolytoxin | 1.26e-06 | 19 | 239 | 5 | CID006440827 | |
| Drug | 1,N6-ethenoadenosine 5'-diphosphate | 1.32e-06 | 34 | 239 | 6 | CID000001312 | |
| Drug | NSC312786 | 2.17e-06 | 21 | 239 | 5 | CID000329495 | |
| Drug | AC1L8NVR | 2.17e-06 | 21 | 239 | 5 | CID000384633 | |
| Drug | chelerythrine | PDE2A ACTBL2 ACTA1 ACTA2 ACTC1 DGKA ACTG2 DGKG NCF4 ITPR1 ADCY4 NSF PRKG2 MARK2 MAP2K3 | 6.17e-06 | 357 | 239 | 15 | CID000002703 |
| Drug | mDia | 6.20e-06 | 93 | 239 | 8 | CID000128346 | |
| Drug | 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | ACTBL2 ACTA1 ACTA2 ACTC1 DGKA ACTG2 DGKG TACR3 ADCY4 NR3C1 TGM1 PRKG2 MAP2K3 MYBPC1 | 6.46e-06 | 314 | 239 | 14 | CID000003542 |
| Drug | azaspiracid | 1.41e-05 | 30 | 239 | 5 | CID006451158 | |
| Drug | NSC-364372 | NCKAP1 APC2 TRRAP ITPKB BID KAT2B FOXG1 GPS1 GRID2 RELB NR3C1 PRPF40A LIMK1 MTOR PRKG2 MAP2K3 HDAC1 | 1.57e-05 | 484 | 239 | 17 | CID000435143 |
| Drug | myo-inositol | DAB2IP DGKA DGKG TRRAP ITPKB ITPR1 KAT2B FIG4 SYK PLCB4 TACR3 CACNA1E ADCY4 ADAP1 TRPA1 GPR183 RGS7 ABHD4 MTOR PDP1 DNM3 MARK2 MAP2K3 | 1.65e-05 | 811 | 239 | 23 | CID000000892 |
| Drug | AC1L1HS4 | 1.95e-05 | 32 | 239 | 5 | CID000004267 | |
| Drug | AC1L9EF8 | 1.96e-05 | 79 | 239 | 7 | CID000443315 | |
| Drug | 9,10-dihydro-9,10-dihydroxybenzo(a)pyrene | 2.14e-05 | 110 | 239 | 8 | ctd:C020738 | |
| Drug | rifampicin | CYP2A6 CYP2A7 CYP2E1 SLCO2B1 KAT2B SULT2A1 FOXG1 NR3C1 PRPF40A USP6 TGM1 ABCG1 MTOR | 2.30e-05 | 306 | 239 | 13 | CID005381226 |
| Drug | 3-methylhistidine | 2.37e-05 | 55 | 239 | 6 | CID000064969 | |
| Drug | N,N'-p-phenylenedimaleimide | 2.65e-05 | 34 | 239 | 5 | CID000076765 | |
| Drug | dihydrocytochalasin B | 3.22e-05 | 58 | 239 | 6 | CID000003064 | |
| Drug | triphosphoinositide | ACTA1 ACTA2 ACTC1 DGKA ACTG2 DGKG TRRAP ITPR1 SCN4A PLCB4 DOCK1 TRPA1 | 3.42e-05 | 273 | 239 | 12 | CID009543520 |
| Drug | D-myo-inositol-1,4,5-triphosphate | ACTBL2 ACTA1 ACTA2 ACTC1 DGKA ACTG2 DGKG ITPKB ITPR1 KAT2B SYK PLCB4 CACNA1E ADCY4 ADAP1 TRPA1 MTOR PRKG2 | 3.44e-05 | 568 | 239 | 18 | CID000000806 |
| Drug | Co-protoporphyrin IX | 3.56e-05 | 118 | 239 | 8 | CID000004972 | |
| Drug | Imipramine hydrochloride [113-52-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A | KANSL1L MAST2 EVI5 ACSL4 PTPN14 HERC6 DOCK1 ELF4 WDFY3 MARK2 | 3.93e-05 | 193 | 239 | 10 | 5440_DN |
| Drug | AC1OAGKW | 3.93e-05 | 193 | 239 | 10 | CID006857413 | |
| Drug | m2-19 | 4.05e-05 | 19 | 239 | 4 | CID000079129 | |
| Drug | Rp-cAMPS | PDE2A ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 SCN4A ADCY4 PRKG2 MAP2K3 | 4.10e-05 | 194 | 239 | 10 | CID006426631 |
| Drug | Methoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 4.29e-05 | 195 | 239 | 10 | 5455_DN | |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; HL60; HT_HG-U133A | 4.48e-05 | 196 | 239 | 10 | 2441_DN | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; MCF7; HT_HG-U133A | IRF6 ATP9B ITPKB EVI5 HERC6 DOCK1 RETREG2 TTC28 ABCG1 MAP2K3 | 4.48e-05 | 196 | 239 | 10 | 3429_DN |
| Drug | parathion | 4.92e-05 | 91 | 239 | 7 | CID000000991 | |
| Drug | AC1OAGFB | ACTBL2 ACTA1 ACTA2 ACTC1 DGKA CDH23 ACTG2 DGKG TRRAP ITPR1 FIG4 SCN4A PLCB4 PLEKHA8 ADCY4 MTOR DNM3 | 6.03e-05 | 539 | 239 | 17 | CID006857345 |
| Drug | orthovanadate | PDE2A ACTBL2 ACTC1 PTPN13 PTS ALG5 SYK QARS1 DNAH9 DYNC1H1 DNAH3 ADCY4 NSF DNAH17 MAP2K3 | 6.13e-05 | 435 | 239 | 15 | CID000061672 |
| Drug | acetaldehyde | CYP2A6 CYP2E1 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 NCF4 DYNC1H1 RELB TESMIN MTOR PDP1 | 6.41e-05 | 338 | 239 | 13 | CID000000177 |
| Drug | epsilon-ATP | 6.73e-05 | 41 | 239 | 5 | CID000162262 | |
| Drug | Biliton | 6.73e-05 | 41 | 239 | 5 | CID000002974 | |
| Drug | 5-IAF | 6.75e-05 | 66 | 239 | 6 | CID000123822 | |
| Drug | NSC613009 | 7.09e-05 | 130 | 239 | 8 | CID000003800 | |
| Drug | DB07328 | 7.37e-05 | 208 | 239 | 10 | CID011840913 | |
| Drug | 9-beta-D-arabinofuranosylguanine | PDE2A NCKAP1 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ITPR1 RBSN PLCB4 MME FOXG1 DOCK1 CACNA1E ADCY4 RGS7 TGM1 LIMK1 MTOR DNM3 PRKG2 RPA2 | 8.65e-05 | 843 | 239 | 22 | CID000000765 |
| Drug | AC1L1BDQ | 9.28e-05 | 173 | 239 | 9 | CID000001394 | |
| Drug | taxol | CYP2A6 CYP2A7 CYP2E1 ACTBL2 ACTA1 ACTA2 NAIP ACTC1 ACTG2 BID ABCF2 RELB PRPF40A MTOR ELF4 MAP2K3 MAP3K2 | 9.60e-05 | 560 | 239 | 17 | CID000004666 |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | PDE2A ACTA1 ACTA2 ACTC1 ACTG2 ITPR1 CNGA1 CACNA1E ADCY4 TRPA1 PRKG2 MAP2K3 | 1.08e-04 | 308 | 239 | 12 | CID000001915 |
| Drug | CHEMBL83995 | 1.10e-04 | 2 | 239 | 2 | CID009571169 | |
| Drug | acylcarnitine | 1.10e-04 | 2 | 239 | 2 | ctd:C116917 | |
| Drug | N-Nitrosopyrrolidine | 1.10e-04 | 2 | 239 | 2 | ctd:D009242 | |
| Drug | 4,4'-dimethylbiphenyl | 1.10e-04 | 2 | 239 | 2 | ctd:C106616 | |
| Drug | AC1L2I2N | 1.10e-04 | 2 | 239 | 2 | CID000021320 | |
| Drug | N-nitrosopiperidine | 1.10e-04 | 2 | 239 | 2 | ctd:C002743 | |
| Drug | 6-phenylhexyl isothiocyanate | 1.10e-04 | 2 | 239 | 2 | ctd:C073279 | |
| Drug | NS-398 | ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 CES2 ACSL4 FOXG1 RELB NR3C1 MAP2K3 | 1.17e-04 | 264 | 239 | 11 | CID000004553 |
| Drug | NSC60597 | 1.19e-04 | 140 | 239 | 8 | CID000003327 | |
| Disease | Moyamoya disease (implicated_via_orthology) | 1.62e-09 | 8 | 233 | 5 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 1.62e-09 | 8 | 233 | 5 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 1.62e-09 | 8 | 233 | 5 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 1.62e-09 | 8 | 233 | 5 | DOID:14004 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | NCKAP1 ITPR1 SYNGAP1 SCN8A FOXG1 DOCK8 CDC42BPB CASK SMC3 WDFY3 | 3.54e-09 | 93 | 233 | 10 | C1535926 |
| Disease | intestinal atresia (implicated_via_orthology) | 7.18e-09 | 10 | 233 | 5 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 7.18e-09 | 10 | 233 | 5 | DOID:13832 (implicated_via_orthology) | |
| Disease | Intellectual Disability | BCKDK APC2 TRRAP SYNGAP1 PTS SCN8A PHIP FOXG1 DYNC1H1 CACNA1E NSF DOCK8 RGS7 MTOR AASS | 3.11e-06 | 447 | 233 | 15 | C3714756 |
| Disease | hippurate measurement | 4.80e-06 | 5 | 233 | 3 | EFO_0010992 | |
| Disease | Large cell carcinoma of lung | 4.98e-06 | 32 | 233 | 5 | C0345958 | |
| Disease | Nephronophthisis | 3.94e-05 | 9 | 233 | 3 | cv:C0687120 | |
| Disease | ornithine translocase deficiency (implicated_via_orthology) | 6.21e-05 | 2 | 233 | 2 | DOID:0050720 (implicated_via_orthology) | |
| Disease | non-syndromic X-linked intellectual disability 63 (implicated_via_orthology) | 6.21e-05 | 2 | 233 | 2 | DOID:0112050 (implicated_via_orthology) | |
| Disease | intellectual disability (is_implicated_in) | 8.84e-05 | 30 | 233 | 4 | DOID:1059 (is_implicated_in) | |
| Disease | Profound Mental Retardation | 1.23e-04 | 139 | 233 | 7 | C0020796 | |
| Disease | Mental deficiency | 1.23e-04 | 139 | 233 | 7 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 1.23e-04 | 139 | 233 | 7 | C0025363 | |
| Disease | disease recurrence, unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 1.30e-04 | 33 | 233 | 4 | EFO_0003761, EFO_0004952, EFO_0008343, MONDO_0004985, MONDO_0005090 | |
| Disease | Cohen syndrome (implicated_via_orthology) | 1.85e-04 | 3 | 233 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | Alzheimer disease, APOE carrier status, age at onset | 1.85e-04 | 3 | 233 | 2 | EFO_0004847, EFO_0007659, MONDO_0004975 | |
| Disease | Microcephaly | 1.91e-04 | 67 | 233 | 5 | C0025958 | |
| Disease | epilepsy (implicated_via_orthology) | 3.28e-04 | 163 | 233 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | platelet component distribution width | HEMGN CHKB ACSL3 PWWP2A TRANK1 SVIL MOV10L1 SYK USP7 ADAP1 DOCK8 POGK JMJD1C BTBD7 DNM3 MYBPC1 | 3.60e-04 | 755 | 233 | 16 | EFO_0007984 |
| Disease | Juvenile Spinal Muscular Atrophy | 3.69e-04 | 4 | 233 | 2 | C0152109 | |
| Disease | Muscular Atrophy, Spinal, Type II | 3.69e-04 | 4 | 233 | 2 | C0393538 | |
| Disease | Muscular atrophy, spinal, infantile chronic form | 3.69e-04 | 4 | 233 | 2 | C2931358 | |
| Disease | HMN (Hereditary Motor Neuropathy) Proximal Type I | 3.69e-04 | 4 | 233 | 2 | C0043116 | |
| Disease | Malignant neoplasm of prostate | DAB2IP CYP2A6 RGMB CYP2E1 LRP1B ITPR1 ACSL4 MET FAF2 SULT2A1 USP7 MME NR3C1 PDP1 | 4.23e-04 | 616 | 233 | 14 | C0376358 |
| Disease | Prostatic Neoplasms | DAB2IP CYP2A6 RGMB CYP2E1 LRP1B ITPR1 ACSL4 MET FAF2 SULT2A1 USP7 MME NR3C1 PDP1 | 4.23e-04 | 616 | 233 | 14 | C0033578 |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 4.29e-04 | 19 | 233 | 3 | DOID:10003 (implicated_via_orthology) | |
| Disease | Nonsyndromic Deafness | 4.63e-04 | 81 | 233 | 5 | C3711374 | |
| Disease | Primary Ciliary Dyskinesia | 5.18e-04 | 47 | 233 | 4 | C4551720 | |
| Disease | odorant-binding protein 2b measurement | 6.11e-04 | 5 | 233 | 2 | EFO_0801859 | |
| Disease | Cocaine Dependence | 8.52e-04 | 139 | 233 | 6 | C0600427 | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 8.70e-04 | 24 | 233 | 3 | DOID:10595 (implicated_via_orthology) | |
| Disease | Sjogren-Larsson syndrome (implicated_via_orthology) | 9.12e-04 | 6 | 233 | 2 | DOID:14501 (implicated_via_orthology) | |
| Disease | retinal disease (implicated_via_orthology) | 9.12e-04 | 6 | 233 | 2 | DOID:5679 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of large intestine | 1.00e-03 | 96 | 233 | 5 | C1319315 | |
| Disease | Cerebellar Diseases | 1.27e-03 | 7 | 233 | 2 | C0007760 | |
| Disease | centronuclear myopathy (implicated_via_orthology) | 1.27e-03 | 7 | 233 | 2 | DOID:14717 (implicated_via_orthology) | |
| Disease | muscular atrophy (implicated_via_orthology) | 1.27e-03 | 7 | 233 | 2 | DOID:767 (implicated_via_orthology) | |
| Disease | mean platelet volume | DOCK11 ACSL3 ACSL4 PWWP2A TRANK1 FBXO28 SVIL SYK USP7 PHIP TTC28 DOCK8 PCDHGA7 CDC42BPB JMJD1C SH2D4A DNM3 ULK2 | 1.32e-03 | 1020 | 233 | 18 | EFO_0004584 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.35e-03 | 152 | 233 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | arylsulfatase A measurement | 1.68e-03 | 8 | 233 | 2 | EFO_0020163 | |
| Disease | Myopathies, Nemaline | 1.68e-03 | 8 | 233 | 2 | C0206157 | |
| Disease | chronotype measurement | CYP2A6 MYCBP2 DGKG ITPKB SYNGAP1 FIG4 SCN8A USP7 PLCB4 QARS1 DOCK1 TSHZ3 TTC28 RGS7 CFAP61 VSX2 | 1.84e-03 | 882 | 233 | 16 | EFO_0008328 |
| Disease | Ovarian Mucinous Adenocarcinoma | 1.86e-03 | 31 | 233 | 3 | C1335167 | |
| Disease | Severe Congenital Microcephaly | 1.86e-03 | 31 | 233 | 3 | C3853041 | |
| Disease | Carcinoma, Small Cell | 2.15e-03 | 9 | 233 | 2 | C0262584 | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 2.15e-03 | 9 | 233 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | non-syndromic X-linked intellectual disability (implicated_via_orthology) | 2.15e-03 | 9 | 233 | 2 | DOID:0050776 (implicated_via_orthology) | |
| Disease | Microlissencephaly | 2.23e-03 | 33 | 233 | 3 | C1956147 | |
| Disease | Cocaine-Related Disorders | 2.41e-03 | 117 | 233 | 5 | C0236736 | |
| Disease | body weight | NBEAL1 DGKG LRP1B ZNHIT3 ITPR1 ACSL3 PTPN14 DOCK1 RPGRIP1L COPG1 PAK5 GRID2 AP3B1 PRDM5 ZFX DNAH12 MTOR DNM3 PRKG2 GPRC5B | 2.53e-03 | 1261 | 233 | 20 | EFO_0004338 |
| Disease | stomach cancer (is_implicated_in) | 2.56e-03 | 72 | 233 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | Kartagener Syndrome | 2.64e-03 | 35 | 233 | 3 | C0022521 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 2.64e-03 | 35 | 233 | 3 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 2.64e-03 | 35 | 233 | 3 | C4317124 | |
| Disease | asthma (implicated_via_orthology) | 2.64e-03 | 35 | 233 | 3 | DOID:2841 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.68e-03 | 10 | 233 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.68e-03 | 10 | 233 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.68e-03 | 10 | 233 | 2 | cv:C4707243 | |
| Disease | meningitis | 3.26e-03 | 11 | 233 | 2 | MONDO_0021108 | |
| Disease | Congenital Nonbullous Ichthyosiform Erythroderma | 3.26e-03 | 11 | 233 | 2 | C0079154 | |
| Disease | Copper-Overload Cirrhosis | 3.26e-03 | 11 | 233 | 2 | C1876165 | |
| Disease | Congenital ichthyosis of skin | 3.26e-03 | 11 | 233 | 2 | cv:C0020758 | |
| Disease | Cocaine Abuse | 3.43e-03 | 127 | 233 | 5 | C0009171 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 3.89e-03 | 12 | 233 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | nicotine metabolite ratio | 3.89e-03 | 12 | 233 | 2 | EFO_0007794 | |
| Disease | age-related hearing impairment | 4.41e-03 | 324 | 233 | 8 | EFO_0005782 | |
| Disease | Charcot-Marie-Tooth disease | 4.45e-03 | 42 | 233 | 3 | cv:C0007959 | |
| Disease | Skin Abnormalities | 4.57e-03 | 13 | 233 | 2 | C0037268 | |
| Disease | Dystonia | 4.85e-03 | 86 | 233 | 4 | C0013421 | |
| Disease | fibromuscular dysplasia | 5.07e-03 | 44 | 233 | 3 | EFO_1000938 | |
| Disease | Malformations of Cortical Development | 5.31e-03 | 14 | 233 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 5.31e-03 | 14 | 233 | 2 | C0431380 | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 5.31e-03 | 14 | 233 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | body surface area | PDE2A DGKG SCN4A COPG1 NR3C1 AP3B1 CDPF1 CREB5 MTOR DNM3 PRKG2 GPRC5B | 5.35e-03 | 643 | 233 | 12 | EFO_0022196 |
| Disease | N-acetylmethionine measurement | 6.09e-03 | 15 | 233 | 2 | EFO_0021427 | |
| Disease | Neuroblastoma | 6.10e-03 | 47 | 233 | 3 | C0027819 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 6.85e-03 | 49 | 233 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 6.93e-03 | 16 | 233 | 2 | C0334634 | |
| Disease | diacylglycerol 44:7 measurement | 6.93e-03 | 16 | 233 | 2 | EFO_0020069 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 6.93e-03 | 16 | 233 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | urinary uromodulin measurement | 7.14e-03 | 96 | 233 | 4 | EFO_0005663 | |
| Disease | Tinnitus, wellbeing measurement | 7.14e-03 | 96 | 233 | 4 | EFO_0007869, HP_0000360 | |
| Disease | Pulmonary Emphysema | 7.81e-03 | 17 | 233 | 2 | C0034067 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 7.81e-03 | 17 | 233 | 2 | cv:C0270914 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VKSYMDMQRRASPDL | 971 | Q13075 | |
| MAAVPEIMDRIYKNV | 371 | O60488 | |
| EQLDLDLSPLEYMMK | 471 | Q9UG63 | |
| HMTLKYEMQLLDELP | 81 | Q9NUN7 | |
| VEDAMKEMQKPLARY | 511 | Q9BRD0 | |
| RLMYPDDDEAMLQKR | 381 | Q86XL3 | |
| LMPIFMRYDTILKET | 196 | Q8NHU2 | |
| LLYLVMDSKTLPMAQ | 221 | Q96FG2 | |
| TLKEILRNPMEAMYP | 196 | Q96AK3 | |
| SRGIFEEMKYLELMI | 291 | O75077 | |
| CIPESMYQKVMEINR | 506 | Q9BXX2 | |
| KLNLENIPRTMLMYD | 206 | Q96LI9 | |
| AYKRLVLMNMPVAED | 1786 | Q15878 | |
| RAKMPYMEAVIHEIQ | 346 | P11509 | |
| RKVSCYIMQDDMLLP | 156 | P45844 | |
| TMYPGIADRMQKEIT | 306 | P68133 | |
| MYPGIADRMQKEIIT | 306 | Q562R1 | |
| VPSYNEEKRLPVMMD | 71 | Q9Y673 | |
| EEKRLPVMMDEALSY | 76 | Q9Y673 | |
| PVMMDEALSYLEKRQ | 81 | Q9Y673 | |
| MAAVQMDPELAKRLF | 1 | Q9Y312 | |
| LSYGPEEKDMIVMRD | 826 | Q9UDR5 | |
| TMYPGIADRMQKEIT | 306 | P62736 | |
| VKMQRPDSYVRDMEI | 301 | Q8TB40 | |
| MYPGIADRMQKEITA | 306 | P63267 | |
| LPAYLAREMKAEIMA | 231 | Q8NFM4 | |
| SLYERGMESLKAMLP | 536 | O94923 | |
| RIPAYEMVMESVKAG | 296 | Q008S8 | |
| TMDDRRLMYFKDPLD | 276 | O75689 | |
| MSKLLNPEEMTSRDY | 61 | Q9NR22 | |
| SMVLLEESYVMKDPF | 36 | Q6NVV7 | |
| YMSTEEMKSLIRLPD | 146 | Q0P5N6 | |
| GLPEMNLLEMYSLKD | 206 | Q9Y259 | |
| NSMKPFKDMDYSRII | 306 | O75907 | |
| YILPELLKNAMRATM | 271 | O14874 | |
| MVKSPMNRELVATYE | 2241 | Q9H251 | |
| RNIIVMGEMEDKCYP | 496 | Q8WUJ3 | |
| MEEKYLMRESKPEDI | 976 | Q8NB25 | |
| ASELRSMLEVNYPME | 61 | P61160 | |
| MPALMEILQSDYILA | 191 | Q5T9G4 | |
| EMEMAVIYLQKLLRG | 491 | Q7Z4T9 | |
| MMLAIKEASADLSPY | 151 | O00203 | |
| PLMRAELQPYMLKEA | 251 | Q8IYR0 | |
| IMLRKIMDSGELDFY | 151 | Q9UKD1 | |
| MREKYENFEDPMGTI | 2076 | Q6ZS30 | |
| DPSDYVRAMREMNGK | 431 | Q9BTD8 | |
| FNILMEDKMNLYPID | 106 | Q9Y5G6 | |
| MEKVDQKAPEYIRMA | 286 | Q9H1K0 | |
| MRRMDPVLSEPVYDK | 281 | Q01201 | |
| SRIPAIKDRQEMPYM | 336 | P05181 | |
| IKDRQEMPYMDAVVH | 341 | P05181 | |
| EKRMPEDLDENMDYR | 41 | Q9NQX1 | |
| IMDPFKIEESVRYMV | 1601 | O00763 | |
| EQAQMLDPYLIKGMD | 261 | Q9UJX3 | |
| MCIPKVDYDRAQMVL | 326 | Q9P286 | |
| TKAELRMLDKDLMPY | 1036 | Q7RTW8 | |
| MIYEESKMNLEQERP | 1 | Q02930 | |
| TITILPMEMYKEFAE | 336 | Q5VWQ8 | |
| MLMLDPAERITVYEA | 256 | O14936 | |
| LDILYTSAVMPKMLE | 71 | Q9GZK7 | |
| EKMLPLSDIYKFIME | 31 | Q5VYV0 | |
| KMLYMESPRTVDEKL | 26 | A0AUZ9 | |
| DAPQRMYSEIIALMK | 381 | Q5VXI9 | |
| RMSNELENYFKPSML | 131 | Q8TAP9 | |
| RGMDLNTKIADEYMI | 536 | Q9NZR2 | |
| EMELKEYNMSGIILR | 546 | Q9BXT6 | |
| VPMNMDLDRYLKSES | 846 | Q68CZ1 | |
| YEVIRFPMDLKTMSE | 761 | Q92831 | |
| PYEKAEDTKMQEIMR | 1231 | Q14643 | |
| MEIYRPHKANAEEMT | 51 | Q13547 | |
| MQPRQSVTDYLMAVK | 511 | Q9Y216 | |
| MYVVDTRPKLNAMAN | 236 | Q96EF0 | |
| NKPDMNYETMGRALR | 256 | Q99607 | |
| LAIALTMYPMRIDES | 371 | Q9Y262 | |
| KDLSEFYRKMIPAMD | 921 | Q9P2D0 | |
| LVMEMAELGPLNKYL | 446 | P43405 | |
| LVLDQDVKPEMAMLY | 981 | O43861 | |
| KYKPRMNELEAFNML | 536 | Q8N6Q8 | |
| KTMMPARYEDLLKSL | 2271 | Q15652 | |
| YMLMQPAAKVDQETL | 271 | Q9NS86 | |
| RYPQKVMDKILSMAE | 91 | Q9NXV6 | |
| MNTIDMYNVTRPIEK | 431 | Q9P1W3 | |
| DEMLRMYQALKEALG | 726 | Q9UQ16 | |
| LIEYFKSQMKEDPDM | 6 | Q14232 | |
| VRMKGLNPFERDSMY | 691 | O43424 | |
| YNALIMMAIRQSPEK | 186 | P55316 | |
| YLKAMTVDRELPEMN | 36 | Q5VSP4 | |
| QISEAAPLYSMIMDK | 1766 | Q9NYQ8 | |
| PVIYSLRNAEMRKAM | 276 | Q8NGF9 | |
| EAKYFQLQPMLLEME | 111 | Q719H9 | |
| EMMDREKAYIPELQI | 846 | O00408 | |
| TLQPGMRVRMLDDYE | 376 | Q14999 | |
| MQDYRLRELFKPSMA | 271 | O60447 | |
| DEMKDNLLLDMYLAP | 346 | Q13098 | |
| PKVMRIYDTQKEMDR | 351 | O00748 | |
| PMMFQRTIESYVDKR | 2491 | Q96JB1 | |
| EIARLQMELMEYKAG | 391 | O75037 | |
| YMMKAFDLIVDRPVT | 26 | O96000 | |
| LPKYSTMERMEEALQ | 991 | Q8IVU3 | |
| RDPQEKTLSIFMEYM | 426 | Q9Y2U5 | |
| EDRNDPMLLYNKMTL | 291 | P08473 | |
| LRPILQEMMKEIDYD | 156 | P23743 | |
| IIFIDDMNMPALEKY | 1956 | Q6ZR08 | |
| EMDYDLELKMISTPS | 401 | Q53F19 | |
| LEDKALMIAMEYAPG | 71 | Q86SG6 | |
| IAEMRIPALNAYMKS | 101 | Q15080 | |
| EDPRMDYAAKLMKNI | 226 | Q9P2J3 | |
| YLKAMTVDREFPEMN | 36 | P31025 | |
| LMLIEMSLQMDPEYR | 711 | P46459 | |
| MSLQMDPEYRVRKFL | 716 | P46459 | |
| DLIINEQRMTLPCMY | 626 | P04150 | |
| MKPSMYEELDRAMLE | 71 | Q9Y4A0 | |
| EVQVMAERYKMLIPF | 181 | Q9NX02 | |
| MQRDLSLYLPAMEKQ | 486 | Q96JA3 | |
| KLPEDMARFYIGEMV | 171 | Q9Y5S2 | |
| RYMQAKGDPITREAM | 271 | Q9P215 | |
| SKMLSLPEELARMYR | 501 | Q9P0J1 | |
| KTLSRMSQNLEPMEY | 206 | Q8TCD6 | |
| RLDPQQIKDMVECMY | 171 | Q13237 | |
| FKMYQDMAKREDLAP | 216 | Q9BXL5 | |
| IPRETDMKVAMNVYE | 946 | Q9Y2A7 | |
| EDRMYPDLSELLMVS | 36 | O75694 | |
| EKMLPLSEIYKFIMD | 31 | Q99853 | |
| AMKCMRPEDVSVLYI | 961 | Q9UG01 | |
| PLIYTLRNKEVMMAL | 286 | Q9UGF7 | |
| EQAMKMIINDPRYSA | 416 | O75400 | |
| LPRAYMENKAFSMDE | 326 | Q9NZH0 | |
| TEMMPVYLDLNKARN | 436 | Q9UII4 | |
| VQKMIENYEALFMVP | 591 | O43182 | |
| LQEKLAMMESGVRDY | 216 | Q66GS9 | |
| LRPILKEMLQGMDYD | 221 | P49619 | |
| VDYEMHKMTRDPLNL | 446 | O95996 | |
| YRLPKSEMDENQIQM | 81 | Q7Z7G2 | |
| EVNRMLTPSEFLKEM | 41 | Q4G0P3 | |
| MMRNEPIEGKLSLYR | 331 | Q8WYA0 | |
| MHPELMKYGRETEQL | 311 | Q5JSL3 | |
| REILLPMMTDQLKYH | 856 | Q14185 | |
| PMMTDQLKYHLERQE | 861 | Q14185 | |
| FQEDPEMLMDLMYRI | 1616 | Q8NF50 | |
| KLVYFIDDMNMPEVD | 2516 | Q9UFH2 | |
| VDYILMDPMERKRLF | 296 | Q8TD57 | |
| IMQPLGKEDSSMYRE | 886 | Q92562 | |
| RTKMPYMEAVIHEIQ | 346 | P20853 | |
| LAYPDKLVMMEQIAQ | 486 | Q96JB2 | |
| YQEAGVLKMTLRDDM | 301 | P17213 | |
| MAMEYFDEKIVPILK | 206 | Q9NVF7 | |
| LMERYLSVKSLPEAM | 761 | Q7Z591 | |
| KPNMTRAEEAMELYH | 361 | Q9P203 | |
| QAYPRDMEKEKTMLV | 136 | P55957 | |
| SEMFAEMDLRAIKPY | 66 | Q86SG7 | |
| PDYKDPRRTELMVSM | 321 | Q7KZI7 | |
| SEIIMMNHVYKERFP | 311 | Q6P0Q8 | |
| MTKPDRQLIAQVMLY | 2041 | Q14204 | |
| YRQPKFLRTMDVFDM | 236 | Q8IYD2 | |
| DPTLRRMCYLTIKEM | 81 | Q9Y678 | |
| ISVLKEMSYLEPREM | 701 | Q9NYC9 | |
| PEYSDVKLVQTMMFL | 366 | Q9ULM6 | |
| SAQEPDKLSMVMYLS | 601 | O94851 | |
| MEHYLPARVMEKLDL | 726 | Q12923 | |
| REFNLMYDGTKEVPM | 91 | O14896 | |
| LRKNPAERMSYLELM | 306 | P46734 | |
| MKSNPLYTDMRLTEL | 806 | Q9UPX6 | |
| MAPDYDHLTLMQKVE | 2271 | P42345 | |
| IASKEMREIPEMEGY | 126 | A6NES4 | |
| KNYEESPERKTLMSM | 401 | Q9Y4I5 | |
| YMEMPLECILTEKRK | 291 | P08581 | |
| LVMEDGKMDPVAYRV | 406 | P47897 | |
| LAIRMPEDLAMSYEE | 291 | Q6NW40 | |
| DESPNMLVYRKMEDV | 16 | P49802 | |
| MYREEPTSIMNAIKL | 301 | Q96N64 | |
| ELDRGYKSIMELMNV | 1006 | Q9UQE7 | |
| KRAMQIIEMYEPDED | 266 | Q15147 | |
| FTAEMVLKLIAMDPY | 621 | P35499 | |
| PGAHEELKLMETLMY | 791 | Q9H5Y7 | |
| PDMAYRLISAKMPEV | 321 | Q5SQN1 | |
| DVKAYDVTRMVSMPQ | 1706 | O95425 | |
| AGDALIYMEPEKQVM | 501 | Q9P2J5 | |
| ILCMKYLMEVNLPDE | 306 | Q53T94 | |
| RKDMYQKMIEVDPEA | 766 | P27987 | |
| RENTYPFLAMIMLKD | 226 | Q96CS3 | |
| MSKQEAERITCMEYP | 171 | P32249 | |
| VPQIPMLREKMEYSA | 721 | Q15678 | |
| LEPLLMQLDYSMKAE | 236 | Q8NC44 | |
| DVPMMAKIAETYSIE | 201 | Q8WV41 | |
| MESYAKALRMLPTII | 436 | P78371 | |
| AREKYAMMFDEPVLL | 1311 | O75592 | |
| EPMIVKEARYIAITM | 2361 | O75592 | |
| MPMREEKNFLLLSYE | 171 | Q06520 | |
| MDMFPDASLIRDLQK | 646 | Q8IYB8 | |
| MTAIAVDRYMAIIDP | 176 | P29371 | |
| PTELVKCRLQTMYEM | 126 | Q9Y619 | |
| PTELVKCRLQTMYEM | 126 | Q9BXI2 | |
| LFLKYDATMIEINPM | 246 | Q9P2R7 | |
| KRYMAPEVLDDSINM | 376 | P36897 | |
| RKLEMEDYPSFMAKR | 341 | Q9NY61 | |
| TMYPGIADRMQKEIT | 306 | P68032 | |
| AAVPEIMDRIYKNVM | 381 | O95573 | |
| DLMEALTEYPDAKTM | 576 | P29973 | |
| YNREKLMEMLKVTEP | 336 | Q6P4Q7 | |
| LMEMLKVTEPYNDLV | 341 | Q6P4Q7 | |
| LDPAQRSLYKDVMME | 31 | O75820 | |
| HDVMSRLVKNEMPYL | 121 | A6PVC2 | |
| MLEKYKQERLEEMFP | 471 | Q2NL82 | |
| MIEYLPECMKVLLDF | 626 | O75762 | |
| LLESVDMMAQNLPYR | 301 | Q96RL7 | |
| MMPIDLGEKTIYLVS | 2476 | Q96RL7 | |
| EQEEKLYMMLPVFNR | 46 | Q8IZQ1 | |
| VYKIDDMTAAPMDVR | 91 | P15927 | |
| LERLVPTAVYQHMKM | 161 | Q8WWQ0 | |
| RLKARYQTMSILPME | 401 | Q96PV0 | |
| LPEAVQLIEKASMMY | 91 | Q99747 | |
| SLMLRLYVDINQMPE | 246 | O94956 | |
| PEERNYDNMLKMLSD | 6 | A1L190 | |
| ALRRMYTDIQEPMLS | 271 | Q9UMX0 | |
| MKPLLRRAMAYETLE | 521 | Q07617 | |
| MMVAEYSLREKLPAN | 391 | P29144 | |
| AYKMMDLEEVIPLDC | 641 | Q96K76 | |
| MDPVVLSYMDSLLRQ | 1 | Q96LD8 | |
| MDIMYAAVDSRKPDE | 1416 | Q9UQD0 | |
| MLKQILSEMYIDPDL | 1 | Q9H788 | |
| ETMQIDERKRPYNSM | 541 | O95391 | |
| EALSLYTKLMNEDPM | 366 | Q92783 | |
| ILPKQSCYMEAREKM | 686 | Q8NDW8 | |
| KYIMSDLSPQERMHI | 921 | Q63HK5 | |
| DLRMFYEKNRSLMPS | 221 | Q8IYT8 | |
| ELMEKAIEMRAYAGL | 426 | Q96AY4 | |
| VSDRNMPSELEYMIV | 2511 | Q7Z7G8 | |
| IRVPREKMVYMTVND | 291 | P17010 | |
| RAGIDDMSMENKPLY | 146 | Q9ULT0 | |
| LTMDIYFDENMKPLE | 411 | P22735 | |
| EPRMENQDKTYTRMK | 421 | Q9H0C3 | |
| ETLDEIAQMMVYVPK | 361 | Q9H497 | |
| LMVNPEMYKLLNGEL | 1626 | O15050 | |
| LVSMDYAISKPDLMS | 321 | Q9ULD5 | |
| NQLRKAVYMMPTEGD | 236 | Q93009 | |
| LMRFMYDPQTDQNIK | 406 | Q93009 | |
| EDKAKLMRAYMQEPL | 121 | Q15649 | |
| LKKYMEEAIMQPLDH | 76 | Q03393 | |
| LVKMMTYIEKRFPED | 2396 | Q9Y4A5 | |
| LPMDSYMDLEITVIK | 711 | P35125 | |
| SEGKEIRYPVMLTAM | 286 | Q6PFW1 | |
| IRYPVMLTAMEKLVA | 291 | Q6PFW1 | |
| IDAYVLPVKLEMEMV | 216 | Q2M3C6 | |
| LRPDISLVDQEMMTY | 456 | Q9NX78 | |
| DMYPLTRMIQDTKQV | 436 | B1ANS9 | |
| YAREMLAMKTELPED | 176 | P58304 | |
| VGMIPDIYEKEVRLM | 171 | Q8NEJ0 | |
| MAPEMINGRSYDEKV | 516 | P53667 | |
| MKNKVAIVDDPRYRM | 1081 | Q00872 |